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SUMMARY 
  
Cytoskeletal protein abnormalities are common features of a number of 
neurodegenerative conditions. However, the potential roles of neurofilaments (NFs) 
in neurodegenerative disease and in ageing-related cellular changes are poorly 
understood. Many models of NF abnormalities in mice have been reported, but how 
ageing affects the NF pathology and the role of ageing in neurodegenerative diseases 
are still unknown. This thesis, therefore, sought to examine the effects of the absence 
of a major class of NF proteins, in NF light (NF-L) knockout (KO) mice, on the 
ageing-related adaptive capacity of other cytoskeletal elements in neurons, and also 
on neurodegeneration-linked alteration of cytoskeletal proteins, cytoskeletal RNA-
binding proteins (TDP-43) and myelin proteins.   
 
The NF-L subunit is considered as an obligate subunit polymer for the assembly of 
NF triplet proteins into neuronal intermediate filaments (IFs). Previous studies have 
shown that NF-L KO mice have substantially reduced axonal intermediate filaments. 
NF abnormalities such as NF accumulation, reduced NF-L mRNA, and NF 
mutations have been described in human neurodegenerative disease.  
 
This thesis has used immunohistochemical and quantitative Western blot techniques 
to examine cytoskeletal changes in the brains of NF-L KO and wild-type (WT) mice 
at different ages. It was demonstrated that depletion of NF-L protein resulted in 
alteration of the expression of a range of cytoskeletal proteins, and disrupts other 
neuronal IF proteins, through ageing. However, there were no gross structural 
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changes in neurons or cytoarchitecture in regions such as the cerebral cortex. In this 
regard, alterations in the expression of other cytoskeletal proteins may compensate 
for decreased NFs.  
 
TDP-43, an NF-L mRNA binding protein, has recently been pathologically 
associated with a number of neurodegenerative diseases of ageing. However, 
mechanisms of TDP-43 pathogenesis are unknown. As TDP-43 is known to bind to 
NF-L mRNA, this thesis used immunohistochemical and quantitative Western blot 
approaches to characterize and quantify the changes of TDP-43 expression and 
distribution in brain and spinal cord of ageing NF-L KO mice as compared to WT 
animals. It was found that a significant increase of TDP-43 protein levels occurred in 
the cortex and lumbar spinal cord in NF-L KO mice at 12 months of age, compared 
to WT mice. Moreover, an increase of phosphorylated TDP-43 was found in the 
cervical spinal cord of NF-L KO mice at 12 months, compared to WT controls. 
 
NFs have a critical role in myelination by regulating axonal diameter. To investigate 
whether deficiency of NF-L protein results in myelin alteration during ageing, this 
thesis measured the relative protein level of myelin basic protein (MBP) by using 
quantitative Western blot. It was demonstrated that the level of MBP was 
significantly reduced in the cortex of NF-L KO mice at 12 months, compared to WT 
mice.  
 
In summary, these findings indicate that pathological and compensatory neuronal 
effects of NF-L KO and reduced NFs are affected by ageing. The absence of NF-L 
protein results in the alteration of NFs and other cytosekeletal, mRNA-binding and 
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myelin proteins during ageing. These results indicate that the absence of NF proteins 
can lead to abnormalities in neurodegenerative disease-related proteins, but also that 
the central nervous system (CNS) is capable of adaptive alterations in the absence of 
NFs. 
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Chapter 1: Literature review and introduction   
 
1.1 Overview 
Abnormal accumulations and mutations of neurofilament (NF) proteins are 
associated with human neurodegenerative diseases, including amyotrophic lateral 
sclerosis (ALS), Charcot-Marie-Tooth disease, Alzheimer’s disease (AD) and 
Parkinson’s disease (PD) (reviewed in Ching and Liem, 2006; Abe et al., 2009; 
reviewed in Perrot and Eyer, 2009; Szaro and Strong, 2010).  
 
Mutations in the NF genes have a close relationship with neurodegenerative diseases. 
For example, mutations in the NEFH gene in humans, have been identified in a small 
number of sporadic ALS patients (reviewed in Al-Chalabi and Miller, 2003). 
Mutations in NEFL gene are associated with Charcot-Marie-Tooth disease (reviewed 
in Liu et al., 2011). Moreover, mutations of the NF-M rod domain have occasionally 
been identified in early-onset PD (Lavedan et al., 2002).  
 
Pathologically, NF abnormalites are frequent findings in many neurodegenerative 
conditions. For example, abnormal phosphorylation of NFs leads to their 
accumulation in cell bodies and has been observed in the brains of AD patients and 
those suffering from other neurodegenerative disorders (Rudrabhatla et al., 2011). 
Moreover, abnormally phoshorylated NFs which are rich in cytoskeletal NF triplet 
proteins (NFTPs) are accumulated in dystrophic neurites adjacent to amyloid  
plaques (Adalbert et al., 2009) and spheroids in proximal axons of lower motor 
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neurons of ALS patients (reviewed in Pasinelli et al., 2006). The accumulation of 
NFs is believed to arise in part from impaired axonal transport. However, it is not 
known if NF disruption precedes transport disruption or whether transport disruption 
is the cause of NF accumulation. These pathological changes may precede overt 
clinical symptoms (Price et al., 1998). However, it is currently unclear if axon 
swellings are associated with overt cell death (Adalbert et al., 2009) 
 
The use of various mouse models provides a better knowledge of the role played by 
the disorganization of intermediate filaments (IFs) in the pathogenesis of 
neurodegenerative disorders (reviewed in Perrot and Eyer, 2009). However, the 
mechanisms leading to the formation of these aggregates remain elusive. In addition, 
previous studies have not looked at how ageing affects NF pathology, an important 
consideration since ageing is central to many neurodegenerative diseases. In this 
thesis, NF light subunit (NF-L) knockout (KO) mice, especially 12-month-old mice, 
were used to explore the roles of NFs in the adult and ageing in the central nervous 
system (CNS), the possibile capacity of the neuronal cytoskeleton to adapt to the 
absence of NFs and the possible role of NF dysregulation in neuropathological 
pathways responsible for neurodegenerative disorders. 
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1.2 Neuronal cytoskeleton   
The neuronal cytoskeleton comprises three different components: NFs (neuronal 
IFs), microtubules (MTs), and microfilaments (MFs) (Figure 1.1). Because neuronal 
cytoskeletal structure plays a particularly prominent role in the nervous system, 
cytoskeletal proteins represent a large fraction of total brain protein, comprising 
perhaps a third or more of the total (Kirkpatrick et al., 1999).   !
1.2.1 NFs 
NFs are a type of  IFs  exclusively expressed within neuronal cells, most prominently 
in large axons (Fliegner and Liem, 1991). IFs are components of the cytoskeleton of 
eukaryotic cells involved in the maintenance of cell shape, locomotion, intracellular 
organization, and transport (Bershadsky and Vasiliev, 1988; reviewed in Ku et al., 
1999). IFs have an average diameter of 10 nm, which is between that of MFs and 
MTs, and consist of six distinct classes of proteins that share common structural and 
sequence features. These types are acidic and basic keratins (type I and II); desmin, 
vimentins, glial fibrillary acidic protein and peripherin (type III); NFs, alpha-
Internexin (INT), syncoilin and synemins (type IV); lamins, phakinin and filensin 
(typeV) and nestin (type VI) (Omary et al., 2004; reviewed in Goldman et al., 2008).  
 
1.2.1.1  The components of neuronal IF 
The primary components of NFs are the NFTPs, INT and peripherin (Fliegner and 
Liem, 1991; reviewed in Ching and Liem, 2006). NFs are heteropolymers that are 
composed of  NFTPs and INT in the CNS; whereas, in the peripheral nervous system 
  
 
 
 
 
 
Figure 1.1 The neuronal cytoskeleton comprises three different components: 
microtubules,  neurofilaments and microfilaments (modified from Fletcher and 
Mullins, 2010, review).  A, microtubules consist of 13 protofilaments of tubulin 
dimers arranged in a hollow tube. B, neurofilaments have flexible polymer arms that 
repel neighbouring neurofilaments and determine the radius of the axon. C, actin 
filaments are arranged into networks with a variety or structural features, including 
the branched structures depicted here, which are formed by the Arp2/3 complex 
(blue). 
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(PNS), NFs are comprised of NFTPs and peripherin (Parysek et al., 1991; Ching and 
Liem, 1998; Beaulieu et al., 1999a).   
 
NFTPs are formed from three subunit proteins: NF high-molecular-weight subunit 
(NF-H, 180 to 200 kDa), NF middle-molecular-weight subunit (NF-M, 130 to 170 
kDa) and NF low-molecular-weight subunit (NF-L, 60 to 70 kDa) (Fliegner and 
Liem, 1991; reviewed in Lee et al., 1996). Mouse NF-H, NF-M and NF-L subunits 
are unable to self-assemble into homopolymer filaments, although  human NF-L can 
do so in vitro (Carter et al., 1998). In this regard, the NFTP subunits are co-expressed 
throughout the neocortex (Vickers and Costa, 1992). NFTPs are expressed 
abundantly in both the CNS and PNS (Fliegner and Liem, 1991; reviewed inLee et 
al., 1996). However, it may not be that all nerve cells comprise these proteins. For 
example, in the cerebral cortex (CTX), NFTPs are predominantly expressed in a 
subpopulation of pyramidal cells of cortical layers II-VI that give rise to 
corticocortical connections (Vickers and Costa 1992; Hof et al. 1995; van der Gucht 
et al. 2007; Paulussen et al. 2011). In the rat neocortex, NFTP-immunopositive 
pyramidal neurons account for approximately 10-13% of all neurons (Kirkcaldie et 
al. 2002).  
 
INT is found primarily in the CNS and minimally in the PNS (Kaplan et al., 1990; 
Fliegner et al., 1994).  In the developing mammalian nervous system, INT proteins 
are expressed earlier and more abundantly than the NFTPs (Kaplan et al., 1990; 
Fliegner et al., 1994). In addition, INT upregulation in injured motoneurons suggests 
that INT may play a role in neuronal regeneration (McGraw et al., 2002). While 
peripherin is predominantly expressed in the PNS and in some neuronal populations 
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of the CNS, this protein also plays a role in neurite elongation during development of 
the nervous system (reviewed in Lariviere and Julien, 2004). Moreover, its synthesis 
appears necessary for axonal regeneration in the adult, but its exact function is 
unknown (Portier et al., 1993). It has been reported that peripherin and INT can self-
assemble or co-assemble with NFTP subunits to form filamentous structures before 
their translocation into the axon (Cui et al., 1995; Beaulieu et al., 1999a, b).  
 
Neurons also express other IF proteins, including nestin (200 kDa), synemin (Low, 
41 kDa, Middle/beta 150 kDa or High/alpha synemin180 kDa), syncoilin (Sync1 64 
kDa, Sync2 64 kDa) and vimentin (57 kDa) (Perrin et al., 2005). Some of these are 
developmentally regulated in neurons and may not be in adult neurons (reviewed in 
Guérette et al., 2007). IFs in astrocytes are primarily composed of glial fibrillary 
acidic protein (GFAP) (reviewed in Liem et al., 2009). Astrocyte precursors of the 
CNS usually express vimentin as the major IF. Astrocyte maturation is followed by a 
switch between vimentin and GFAP expression, with the latter being recognized as 
an astrocyte maturation marker (Gomes et al., 1999). 
 
1.2.1.2 The stucture of NF 
Like other IFs, NF subunits consist of a globular amino-terminal head, a highly 
conserved α-helical rod domain, and variable carboxy-terminal tail domains (Figure 
1.2). All NF subunits (NF-H, NF-M, NF-L, INT and peripherin) share a highly 
conserved central rod domain of 310 amino acid residues, which is responsible for 
the formation of coiled-coil structures (Parry et al., 1985; Hisanaga et al., 1988; 
reviewed in Herrmann et al., 2009). Flanking this central rod domain are the amino- 
  
 
 
 
 
 
Figure 1.2 Structure of NF proteins (adapted from Lariviere and Julien, 2004a, 
review). All IF subunits share a highly conserved central domain of 310 amino acid 
residues involved in the formation of coiled-coil structures. Flanking this central rod 
domain are the amino- and the carboxy-terminal domains. These two end domains 
present a higher degree of variability among NFs and they may confer functional 
specificity to the different types of NF proteins. 
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and the carboxy-terminal domains. These two end domains present a higher degree 
of variability among NFs and they may confer functional specificity to the different 
types of NF proteins (Carpenter et al., 1996). Interestingly, the NF-M and NF-H 
carboxy-terminal regions contain multiple repeats of the motif Lys-Ser-Pro (KSP), 
which is a site for phosphorylation and accounts for the unusually high content of 
phosphoserine residues in these proteins (reviewed in Lariviere and Julien, 2004).  
  
1.2.1.3   NF assembly  
The current model of a 10-nm IF structure (Steinertet al., 1988; reviewed in Liu et 
al., 2004a) is that of two coiled-coil dimers of protein subunits that line up in a 
staggered fashion to form an antiparallel tetramer. Eight tetramers packed together in 
helical array are required to make a ropelike 10-nm filament (Figure 1.3). 
 
However, there are features of NF assembly that differ from other types of IFs 
(reviewed in Liu et al., 2004a). First, NFs consists of four subunit proteins: NF-L, 
NF-M, NF-H and INT or peripherin (Parysek et al., 1991), whereas other IFs are 
either homopolymers, or heteropolymers consisting of two polypeptides. Secondly, 
only NFs demonstrate 4-6 nm wide sidearm structures, which correspond to the 
carboxy-terminal domain of the proteins. In axons, these sidearms span the 
intracellular space between filaments, appearing to cross-link them together 
(Hisanaga and Hirokawa, 1989). Because of this morphological specialization, NFs 
often appear parallel to one another and to the long axis of the axon. In this regard, 
NF spacing is widely believed to be an important determinant of axonal caliber in 
large myelinated axons (Hoffman et al., 1987). Thirdly, the NFTPs possess carboxy-
  
 
 
 
 
 
Figure 1.3 Schematic model of NF assembly (adapted from Liu et al., 2004a, 
review). In the NF assembly process, two NF subunits (NF-L, and either NF-H or 
NF-M) form head-to-tail coiled-coil dimers, anti-parallel half-staggered tetramers, 
protofilaments, and 10-nm NFs. There are ~32 molecules in the crosssection, and 
hyperphosphorylated side arms formed by the C-termini of NF-H and NF-M project 
out of the stem of the filament.  
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terminal tail domains that differ greatly in size and type of sequence motifs. All three 
NF proteins contain one or more glutamic acid-rich regions. As described earlier, 
NF-M and NF-H have atypically long tail domains containing multiple KSP repeats, 
which are phosphorylation sites (Carpenter et al., 1996). The tail domains of these 
two polypeptides are therefore expected to be highly charged, and are believed to 
provide repulsive forces that maintain NFs in an axon at finite separations (reviewed 
in Liu et al., 2004a). 
 
NFTPs play important roles in NF assembly (Jones and Safinya, 2008). NF-L is 
essential for the precise assembly of NFs, for NF formation is believed to start with 
the dimerization of NF-L with either NF-M or NF-H subunits (Ching and Liem, 1993; 
Lee et al., 1993; Zhu et al., 1997). NF-M participates in the formation of cross-
bridges, stabilization of the filament network and longitudinal extension (Elder et al., 
1998a; Elder et al., 1999a, b; Jacomy et al., 1999). NF-H also contributes to the 
formation of cross-bridges and may interact with MTs/MFs and other cytoskeletal 
elements (Elder et al., 1998b; Elder et al., 1999b; Jacomy et al., 1999). 
 
1.2.1.4 Modifications of  NFs 
NFs demonstrate a variety of post-translational modifications, such as 
phosphorylation, glycosylation and ubiquitination (reviewed in Perrot et al., 2008). 
The phosphorylation of the conserved KSP motifs located on the tail domain of NF-
H and NF-M are the most frequent post-translational modification (Julien et al., 1981, 
1982, 1983). However, phosphorylation of “non-KSP” serine residues within head 
domain of NF-M and NF-L has been described (Zheng et al., 2003).  
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Phosphorylation of the tail domain of NFs is specific for particular domains within 
the nerve cell, with non-phosphorylated tails predominately found in the cell bodies, 
with this region of the NF protein becoming highly phosphorylated in mature axons 
(Hashimoto et al., 2000). Phosphorylation of the tail domain can regulate both the 
interactions between the NF domains themselves and with MTs (Hisanaga and 
Hirokawa, 1989; Hisanaga et al., 1991). Tail phosphorylation is also the crucial 
modification that confers the resistance of NFs to proteolysis (Pant, 1988).  
 
Phosphorylation of the head domain of NFs may play a role in maintaining the 
disassembled state of NFs, as head domain phosphorylation of NF-L inhibits NF 
assembly (Hisanaga et al., 1990a; Sihag and Nixon, 1991; Sihag et al., 1999). 
Phosphorylation of the NF head domain is mediated by the second messenger 
dependent kinases, protein kinase A and C (Sihag et al., 1988; Sihag and Nixon, 
1989; Sihag and Nixon, 1990) and possibly also by Cam kinase II (Hashimoto et al., 
2000). The kinases and phosphatases that are known to control phosphorylation of 
NFTPs are deregulated in the disease state (reviewed in Yuan et al., 2012). The 
accumulated NFs in neuronal perikarya and proximal axons are aberrantly 
phosphorylated (reviewed in Julien et al., 1999). 
 
1.2.1.5  NF protein expression during development 
Nervous system development is accompanied by a differential expression of the 
various NF proteins. The NFTP subunits appear early and simultaneously in central 
and peripheral neurons and are also expressed in mature neurons of both the CNS 
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and PNS (Cochard and Paulin, 1984; Ching and Liem, 1993). Initial NF-L 
expression is detected at the beginning of neuronal differentiation, often overlapping 
with INT and peripherin expression (Willard and Simon, 1983; Carden et al., 1987). 
The NF-M subunit is expressed shortly after with the emergence of neurite formation 
whereas the NF-H subunit is expressed later in neuronal differentiation during the 
postnatal period in mouse development (Carden et al., 1987). INT is expressed 
abundantly in young neurons of the developing the CNS and PNS, but in the adult it 
is found primarily in the central neurons (Pachter and Liem, 1985; Chien and Liem, 
1994). However, in most adult peripheral nerves, INT is markedly downregulated 
during embryonic development to hardly detectable levels, and its disappearance 
from the PNS coincides with the appearance of  peripherin (Escurat et al., 1990). 
 
1.2.1.6  NF transport  
NFs in most neurons are continually synthesized in the perikarya and transported 
along axons (Hoffman and Lasek, 1975; Black and Lasek, 1980; Willard and Simon, 
1983; reviewed in Nixon, 1998a, b, c). The mechanism is known as the "Stop and 
Go" model of slow axonal transport, and has been extensively validated for the 
transport of the NFs (Brown, 2003). However, the movement of NFs is actually 
rapid, but unlike fast axonal transport, they pause frequently, making the overall 
transit rate much slower (Sunil et al., 2012).  
 
The current understanding of NF transport is that they are transported bi-
directionally in the axon along MTs through motors. The molecular motors that 
regulate axonal transport of NF subunits have been proposed to be the MT-based 
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motors, kinesin and dynein (Prahlad et al., 2000; Wagner et al., 2004), and MF-based 
motor myosin Va interactions with actin (Alami et al., 2009). Kinesin regulates 
anterograde axonal transport of NFs (Prahlad et al., 2000; Xia et al., 2003) while 
dynein regulates retrograde NF transport (Yabe et al., 1999; Roy et al., 2000; Wang 
et al., 2000). In addition, phosphorylation of NFs (mainly on NF-H) results in their 
dissociation from the kinesin motor, thereby decreasing their transport speed (Yabe 
et al., 1999).  
 
Transport of NF subunits does not require the formation of complete NFs. Minimal 
requirement for axonal transport is the formation of heterodimers that involve 
specific NF subunits (reviewed in Yuan et al., 2012). NF-M and INT have been 
identified as the subunits that are crucial for the transport of dimers of NFs, as 
deleting both prevents transport of NF-L and/or NF-H, whereas deleting either NF-
H, NF-L or both, only minimally alters NF-M or INT transport in optic axons (Yuan 
et al., 2003; Yuan et al., 2006a; Yuan et al., 2006b).  
 
Studies on mouse optic nerve have led to the proposal that only a small proportion of 
NFs are being transported in axons and that the majority are localised to a 
persistently stationary and extensively cross-linked cytoskeletal network that remains 
fixed in place for months without movement (Li et al., 2012). Gene-targeting of 
KIF5A, which encodes a neuronally expressed isoform of conventional kinesin, has 
been found to lead to the accumulation of NF-H, NF-M, and NF-L within the cell 
bodies of peripheral sensory neurons (Xia et al., 2003). Moreover, inhibition of 
dynein activity leads to the accumulation of NFs in the axons of dynamitin-
transgenic mice (LaMonte et al., 2002). The regulated action of molecular motors on 
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NFs can have dramatic effects on NF organization, which may have important 
implications for the mechanisms by which NFs accumulate normally in axons during 
development, and the mechanisms by which they accumulate abnormally and 
excessively in many neurodegenerative diseases (Li et al., 2012). 
 
1.2.1.7  The roles of  NF  
In neurons, NFs exhibit an unusual degree of metabolic stability, which makes them 
potentially well suited for a role in stabilizing and maintaining neuronal morphology 
(Lasek et al., 1988). NFs have been proposed to be essential for the maintenance of 
axon caliber, the radial growth of axons during development and dendritic 
arborization (Friede and Samorajski, 1970; Ohara et al., 1993; Eyer and Peterson, 
1994; reviewed in Yuan et al., 2012). However, the precise functions of NF proteins 
in neurons have remained elusive, also as to why neuronal subpopulations are 
comprised of differing sets of neuronal IF proteins.  
 
The basic function of NF may be to support the axonal structure.  NFs interact with 
MTs and MFs to enhance structural integrity, cell shape, and cell and organelle 
motility (reviewed in Liu et al., 2004a). The head domains of all NFs have a MT 
polymerization inhibitory domain that regulates the number of MTs in the axon 
(Bocquet et al., 2009). The rod domains have important roles in the polymerization 
of NF subunits into IFs, and serve as a binding site for the myosin Va motor protein, 
which modulates levels and local topography of specific vesicular organelles 
(endoplasmic reticulum, endosomes, synaptic vesicles) within the axoplasm (Rao et 
al., 2011). Loss of NF-L or myosin Va partially depletes these organelles from axons 
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(Rao et al., 2011). 
 
NFs, particularly in phosphorylated forms, can regulate cellular and axonal volumes, 
and are primary determinants of axonal caliber in large fibers (Zhu et al., 1997). In 
addition, NFs play an important role in  the radial growth of axons during 
development. Replacement of NF-M (Garcia et al., 2003; Rao et al., 2003) or both 
NF-M and NF-H (Garcia et al., 2003) with versions missing the C-terminal tails that 
extend from the filament surface and contain the KSP repeat motifs resulted in axons 
with diminished radial axonal growth (Garcia et al., 2003; Rao et al., 2003). 
However, phosphorylation of NF-M KSP repeats is not an essential component for 
the acquisition of normal axonal caliber mediated by myelin-dependent outside-in 
signaling (Garcia et al., 2009). Relatively decreased axon caliber accompanied by 
reduced conduction velocity has been observed in mutant Japanese quail that lack the 
NF-L gene (Sakaguchi et al., 1993). Normal axonal caliber but decreased conduction 
velocity has been observed in NF-H KO mice, indicating that NFs potentially have 
roles beyond being determinants of the physical dimensions of axons (reviewed in 
Nixon and Shea, 1992; Kriz et al., 2000). A recent report by Schulz and his 
colleagues suggests that Merlin-iso2 expressed in axons, mediates NF 
phosphorylation and axonal radial growth (Schulz et al., 2013). However, the precise 
mechanism by which NF protrusions regulate axonal diameter remains to be fully 
understood.  
 
NFs are thought to be potential candidates for contributing to axonal outgrowth. The 
evidence suggesting that NF proteins might facilitate axonal elongation by stabilizing 
the cytoskeleton and inhibiting the retraction of long axons, comes from the injection 
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of anti-NF-M antibodies into Xenopus laevis embryos at the two-cell stage followed 
by the analysis of dissociated spinal cord cultures (Lin and Szaro, 1995). By the 
second day of axon outgrowth, the injected anti-NF-M antibodies produced shorter 
axons, both in intact embryos and in culture (Lin and Szaro, 1995). On average, the 
neurites from anti-NF-M containing neurons grow slower than the normal ones (Lin 
and Szaro, 1995; Walker et al., 2001).   
 
NFs may also be required for regulating dendritic arborization. For example, a 
deficiency of NF-L levels in mice can cause reduction of dendritic arborization 
(Zhang et al., 2002). In addition, overexpression of NF-H or NF-M in mice leads to 
alteration in dendritic arborization (Kong et al., 1998). 
 
1.2.2 MTs 
Electron crystallography studies have demonstrated that MTs are composed of α- and 
β-tubulin dimers (Nogales et al., 1998). Heterodimers of α- and β-tubulin align end 
to end to form protofilaments, 13 of which join laterally to form a hollow tube with 
an outer diameter of 25 nm (Hyams et al., 1994). MTs have been regarded as 
essential structures for stable neuronal morphology, motility in development and 
neuroplasticity following injury (Bouquet et al., 2004), but new studies are 
highlighting their role in dynamic neuronal processes, such as the identity of axons  
and the dynamics of dendritic spines (Hoogenraad et al., 2009).  
 
MT-associated proteins (MAPs) interact with MTs to regulate their stability rather 
than with free tubulin and maintain constant stoichiometry with the tubulin in MTs 
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through cycles of assembly and disassembly (reviewed in Schoenfeld and Obar, 
1994). The identified MAPs have been classfied into two categories based on their 
molecular weights: Type I (the high-molecular-weight MAPs, >270 kDa) including 
MAP1A, MAP1B, MAP2A and MAP2B, and type II (the low molecular weight 
MAPs, 30-60 KDa) including tau proteins, MAP3, MAP4 and the molecular motors 
such as kinesin and dynein (Maccioni and Cambiazo, 1995; reviewed in Lace et al., 
2007). Some MAPs are differentially distributed in neurons. For example, MAP1 is 
localised to axons and dendrites, MAP2 is present primarily in cell bodies and 
dendrites, and tau is enriched in axons (reviewed in Schoenfeld and Obar, 1994; 
Matsunaga et al., 1999). In contrast to the MAPs described above, MAP4 is not only 
confined to nerve cells, but also be found in all non-neuronal vertebrate cells 
(reviewed in Schoenfeld and Obar, 1994).  
  
Both MAP2 and tau are able to stabilize MTs by binding to the outer surface of the 
tubulins to promote tubulin assembly into MTs (reviewed in Drewes et al., 1998). 
Misfolded tau proteins can form extremely insoluble aggregates that contribute to a 
number of neurodegenerative diseases (Santarella et al., 2004). Like MAP2 and tau, 
MAP4 can contribute to the stabilization of MTs (Santarella et al., 2004). In addition, 
MAP4 has been involved in the process of cell division (Permana et al., 2005). These 
categories of MAPs possess similar carboxyterminal amino acid sequences despite 
the difference in molecular weights. MAPs are primarily cytoskeleton structural 
components, involved in MT-dependant organization of the cytoplasm through 
interactions with other subcellular components (Avila et al., 2008). While MAPs 
regulate nucleation and stability of MTs, these may not be their primary functions. 
Other MAP functions include roles in MT spacing and organization, 
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compartmentation and interaction with other cellular structures (reviewed in Van der 
Vaart et al., 2009). Because they contribute to most cellular functions, MAPs are 
likely regulated in response to extracellular and intracellular signals (reviewed in 
Etienne-Manneville et al., 2010). One of the major mechanisms is the modification 
of the phosphorylation state of MAP proteins via changes in the relative activities of 
protein kinases and phosphatases within neurons. For example, the MAP2 proteins 
serve as substrates for most of protein kinases present in neurons and MAP2 
phosphorylation is developmentally regulated (Sánchez et al., 2000). The regulation 
of MAP2/tau protein function in signaling networks can control the morphogenesis 
of neurons (Reviewed in Cassimeris and Spittle, 2001). However, the connection 
between signaling pathways and regulation of MT dynamics by MAPs remain 
obscure. 
 
The interactions of MTs with MAPs and motor proteins are also essential for the 
formation and maintenance of the polarized morphology of neurons and are 
regulated in part by post-translational modifications of tubulin (Peris et al., 2009). 
Both α- and β-tubulin subunits of neuronal MTs are subject to a variety of 
modification (Westermann et al., 2003), such as acetylation of α-tubulin, 
phosporylation of β-tubulin and the tyrosination/detyronisation of α-tubulin (Mullins 
et al., 1994; Utreras et al., 2008).  
 
The two best-studied post-translational modifications of tubulin are α-tubulin 
detyrosination and acetylation (reviewed in Luduena, 1993). Most α-tubulins are 
expressed with a carboxy-terminal tyrosine residue, which can be removed by 
tubulin carboxypeptidase and then replaced by tubulin tyrosine ligase, in a rapid 
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cycle that occurs on the majority of available tubulin. Since the carboxypeptidase 
acts only on assembled tubulin and the ligase acts on unassembled tubulin, this 
tyrosination/detyrosination cycle is linked to MT dynamics (Myers et al., 2006). The 
longer that MTs remain polymerized, the higher the content of de-Tyr-tubulin or 
Glu-tubulin (detyrosinated tubulin, in which the C-terminal tyrosine of α-tubulin is 
removed by tubulin carboxypeptidase) (Myers et al., 2006). It has been inferred that 
stable neuronal MTs are detyrosinated, because inhibiting the tubulin-tyrosine ligase 
did not alter the global dynamics of MTs (Webster et al., 1990). α-Tubulin is also 
acetylated at position lysine 40 (reviewed in Palazzo et al., 2003). This modification 
is predominantly associated with stable MTs in structures such as the axoneme 
(reviewed in Palazzo et al., 2003). Acetylation might affect MT stability, directly or 
indirectly, through the binding of plus-end proteins such as Bim1 and Bik1 (the 
homologs of mammalian EB1 and CLIP-170, respectively) at Glu-tubulin ends 
(reviewed in Schuyler and Pellman, 2001; reviewed in Palazzo et al., 2003; Blake-
Hodek et al., 2010). 
 
However, the precise mechanisms of the properties of post-translationally modified 
MTs have been poorly understood until recently. The identification of tubulin 
deacetylase, such as histone deacetylase 6, and discovery of its specific inhibitors 
(Matsuyama et al., 2002) has paved the way to understand the roles of acetylated 
MTs in kinesin-mediated axonal transport and neurodegenerative diseases. Recent 
work has demonstrated that detyrosination impairs MT disassembly in neurons and 
inhibits the activity of the neuronal depolymerizing motor KIF2A in vitro, which 
indicates that MT depolymerizing motors are directly inhibited by the detyrosination 
of tubulin, resulting in the stabilization of cellular MTs (Peris et al., 2006). Tubulin-
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tyrosine ligase (TTL), the enzyme that catalyzes the addition of a C-terminal tyrosine 
residue to α-tubulin in the tubulin tyrosination cycle, is involved in tumor 
progression and has a vital role in neuronal organization(Peris et al., 2006). In TTL-
null fibroblasts, tubulin detyrosination and cytoskeleton-associated protein glycine 
(CAP-Gly) protein mislocalization correlate with defects in both spindle positioning 
during mitosis and cell morphology during interphase (Peris et al., 2006). Studies 
with TTL- KO mice have shown that tyrosinated MTs are essential in normal brain 
development (Erck et al., 2005). The discovery of TTL-like genes encoding 
polyglutamylase has led to the finding that polyglutamylated MTs which accumulate 
during brain development are involved in synaptic vesicle transport or neurite 
outgrowth through interactions with motor proteins or MT-associated proteins, 
respectively (reviewed in Fukushima et al., 2009). However, a mechanistic 
explanation for the long-recognized correlation between MT stability and tubulin 
tyrosination remains elusive. 
 
MTs are highly dynamic and play an important role in the elongation of axons and 
the guidance of growth cones (Dent et al., 2003). In neuronal growth cones, 
interactions between MTs and actin filaments in filopodia are necessary for growth 
cones  turning (reviewed in Geraldo and Gordon-Weeks, 2009). Growth-cone turning 
is a fundamental behaviour during axon guidance, as correct navigation of the 
growth cone through the embryo is required for it to locate an appropriate synaptic 
partner (reviewed in Geraldo and Gordon-Weeks, 2009). Some studies have 
demonstrated that attractive growth cone turning can be initiated by localized MT 
stabilization in conjunction with actin dynamics (Buki and Zheng, 2002). Recent 
experiments suggest that microtubule-actin filament interactions might also be 
Chapter 1 – Introduction 
 
18 
" 
important for the formation of dendritic spines from filopodia in mature neurons 
(reviewed in Geraldo and Gordon-Weeks, 2009).    
 
MTs not only play a vital role during neuronal development but also modulate the 
post-injury sprouting response of damaged axons (Chuckowree and Vickers, 2003). 
However, MTs are not restricted to growth cones and can dynamically reorganize to 
form axon collateral branches (Dent and Kalil, 2001; Schaefer et al., 2002; Wang and 
Brown, 2002; Kalil and Dent, 2005). In this regard, calcium transients are proposed 
to play an important function in modulating MT dynamics (Dent et al., 2004; 
Hutchins and Kalil, 2008). 
 
In addition, MTs play an important role in axonal transport required to maintain 
proper neuronal function in nerve cells. MT networks are responsible for the bi-
directional (anterograde and retrograde directions) movement of membrane bound 
organelles along axons and dendrites (Baas et al., 2006) that is facilitated by the 
motor proteins—kinesin for anterograde transport (Myers et al., 2006) and dynein for 
retrograde transport (reviewed in Hirokawa, 1998). Kinesins move towards the MTs' 
plus end, while dyneins "walk" to the minus end of the MTs (Karp, 2005). Kinesins 
and dyneins both use the energy of ATP hydrolysis to move along the surface of 
MTs (Karp, 2005; Uchida et al., 2009; reviewed in Verhey and Hammond, 2009).   
 
The C-terminal domains of NF-M and NF-H  bind  MTs, either directly (Hisanaga et 
al., 1990b; Hisanaga et al., 1991; Miyasaka et al., 1993) or using MAPs as linkers 
between NFs and MTs (Hirokawa et al., 1988). In addition, NF-L  contain sites in its 
N-terminal domains able to bind un-polymerized tubulin (Berges et al., 2012). The 
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bi-directional motility of NFs along MTs has been reconstituted in vitro (Shah et al., 
2000).  
 
1.2.3 MFs 
MFs are formed by polymerization of the monomeric globular protein—actin that are 
arranged like two strings of pearls intertwined into fibrils 7nm in diameter (Theriot et 
al., 1994). MFs play an important part in cell migration, cell adhesion, cell division, 
and many other essential cellular functions.  
 
MFs are found throughout neurons and glia, but they are enriched in cortical regions 
of the cell near the plasmalemma and are particularly concentrated in presynaptic 
terminals, dendritic spines and growth cones (Kuczmarski and Rosenbaum, 1979). 
MFs primary role in mature neurons is as the main components of the membrane 
cytoskeleton (Hitt and Luna, 1994). MFs also play critical roles in growth cone 
motility and axon outgrowth (Dent and Gertler, 2003). The rapid remodeling of 
filopodia-actin-rich plasma-membrane protrusions, is required for cell migration and 
neurite outgrowth (reviewed in Mattila and Lappalainen, 2008). In addition, MFs are 
involved in the transportation of vesicles along the axon, and in their clustering at the 
plasma membrane sites where exocytosis takes place (Noda and Sasaki, 2008). The 
dense filamentous network of MFs beneath the plasma membrane is reorganized 
upon cell stimulation to allow the access of vesicles to fusion sites (Noda and Sasaki, 
2008). 
 
The submembrane actin cortex and/or its associated motor myosin may facilitate 
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axonal transport of NFs (Jung et al., 2004). Within the super family of myosin 
motors, myosin V is highly enriched in brain, and exists as three different isoforms in 
vertebrates: Myo Va, Vb and Vc (Rodriguez et al., 2002). It has been found that Myo 
Va binding to NF-L modulates the distribution of vesicular organelles in axons (Rao 
et al., 2011).   
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1.3 Pathology of  NF 
NF abnormalities including NF mutation, disregulation of protein synthesis, 
defective axonal transport, and abnormal phosphorylation, have been demonstrated 
in many human neurodegenerative diseases such as Alzheimer’s disease, 
Amyotrophic lateral sclerosis, Pakinson’s disease, Frontotemporal Lobar 
Degeneration and Charcot-Marie-Tooth disease (reviewed in Liu et al., 2011). 
Abnormal accumulation of NFs is a common hallmark of these disorders (reviewed 
in Yuan et al., 2012). 
 
1.3.1   Alzheimer’s disease (AD) 
AD is the most common neurodegenerative disease in the elderly and is the major 
subtype of dementia (Sosa-Oritz et al. 2012). Patients with AD suffer from 
neurological dysfunctions resulting in memory loss, as well as cognitive and 
functional decline. AD is characterized pathologically by the formation of 
intracellular neurofibrillary tangles (NFTs) (Terry, 1963), extracellular deposition of 
amyloid plaques (reviewed in Kidd, 1964; Terry et al., 1964; Busche et al., 2008) 
and the loss of neurons and synapses in certain brain areas (Whitehouse et al., 1982). 
 
NFTs consist predominantly of abnormally modified tau protein, but also contain NF 
proteins, ubiquitin and other cytoskeleton proteins (Perry et al., 1985; Vickers et al., 
1992, 1994). Tau protein and NF proteins found in NFTs are extensively 
phosphorylated (Perry et al., 1987). The vulnerability of NFTs containing 
subpopulations of pyramidal neurons in AD has been attributed to co-expression of 
abnormally phosphorylated NF and tau protein revealing an interference between tau 
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and NF phosphorylation (Ahlijanian et al., 2000; Yang et al., 2009). It has been 
reported that amyloid plaques in AD can result in structural and functional disruption 
of neuronal networks (Kuchibhotla et al., 2008), and that the earliest stages of plaque 
formation are associated with dystrophic neurites principally comprised of NF 
proteins (Vickers et al., 1996). The evidence that NFs play a role in the pathogenesis 
of AD is strengthened by the finding that NF protein expression levels are altered 
(McLachlan et al., 1988) and phosphorylation of NF-M is increased (Deng et al., 
2008) in the AD brain. 
 
1.3.2  Amyotrophic lateral sclerosis (ALS) 
ALS is a progressive, fatal neurodegenerative disease caused by the degeneration of 
motor neurons (Carpenter et al., 1968; Hirano et al., 1984). Intraneuronal 
accumulation of phosphorylated NF proteins in the perikarya and axons of 
degenerating motor neurons is a primary neuropathologic hallmark of ALS (Manetto 
et al., 1988; reviewed in Leigh et al., 1989; Murayama et al., 1992). A five-fold 
increase of NF-H level in cerebrospinal fluid  samples of ALS patients compared to 
controls has been reported, suggesting NF-H level can be a marker of axonal damage 
(Brettschneider et al., 2006).  
 
Pathogenic NEFH mutations have been found in a small number of sporadic and 
familial ALS (reviewed in Liu et al., 2004a). Four novel codon deletions and one 
novel insertion in the KSP region have also been  detected in the tail domain of NF-
H  in a small number of sporadic cases of ALS (Al-Chalabi et al., 1999; Tomkins et 
al., 1998). These mutations would likely affect NF assembly in the neurons (Sasaki 
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et al., 2006) and NF transport (Yates et al., 2009). 
 
NF-L protein is very susceptible to peroxynitrite-mediated nitration, which has been 
suggested as one possible mechanism of ALS pathogenesis (Crow et al., 1997). The 
reduced NF-L mRNA levels by up to 70% seen in degenerating neurons of ALS 
patients has been linked to perikaryal accumulation of NF proteins and axonal 
hypertrophy in motoneurons (Strong et al., 1998; Wong et al., 2000). The decline in 
NF-L mRNA levels associated with degenerating neurons in ALS (Bergeron et al., 
1994) may contribute to increased oxidative damage of other cellular components 
and, therefore, may exacerbate disease progression (reviewed in Julien et al., 1999). 
 
1.3.3  Pakinson’s disease (PD) 
PD is a neurodegenerative disorder, characterized by progressive degeneration of 
dopaminergic neurons in the substantia nigra (Trimmer et al., 2004). The major 
pathological hallmark of PD is the Lewy body in the degenerating neurons. Lewy 
bodies are an inclusion composed of numerous proteins including alpha-synuclein, 
NFTP subunits, ubiquitin and proteasome subunits, torsinA and parkin (Galloway et 
al., 1992; Trimmer et al., 2004). 
 
Reduced protein level of NF-M and NF-L has been detected in brain of PD patients 
(Basso et al., 2004). NF-L mRNA is also decreased, correlating with the severity of 
the disease of PD (Hill et al., 1993). A 16-year-old PD patient showed a point 
mutation in the region of the NEFM gene coding for the rod domain 2B of NF-M 
protein, which results in substitution of serine for glycine at residue 336, and was 
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argued to disrupt NF assembly (Lavedan et al., 2002). However, this NEFM gene 
mutation was screened in another 322 PD patients and no further similar mutations 
were found (Kruger et al., 2003).  
 
1.3.4   Frontotemporal Lobar Degeneration (FTLD) 
FTLD is the second most common form of early-onset neurodegenerative dementia 
after AD, sharing a propensity to produce selective brain atrophy predominantly 
involving the temporal or frontal lobes due to deposition of pathogenic proteins 
(reviewed in Graff-Radford and Woodruff, 2007).  
 
Neuronal cytoplasmic inclusions, which are ubiquitin-positive, in the neocortex, 
striatum and the dentate fascia of the hippocampus (HIP) are the pathological 
hallmarks of FTLD (Mackenzie et al., 2005).  A number of different proteins such as 
tau, TDP-43 and FUS pathology are associated with pathological includions in FTLD 
(van der Zee et al., 2007). Approximately 50% of FTLD cases will present with tau 
pathology at post-mortem (Bugiani, 2007). TDP-43 pathology, which is described as 
dementia with ubiquitin positive, tau- and alpha-synuclein negative inclusions with 
and without motor neuron degeneration, accounts for approximately 40% of FTLD 
(reviewed in Lee et al., 2011). FTLD-FUS represents only 5–10% of clinically 
diagnosed FTLD (reviewed in Lee et al., 2011). 
 
Several genetic mutations have been found that are the cause of FTLD and result in 
these pathological inclusions. A mutation in the gene encoding the progranulin 
protein was found to be a common cause of FTLD in families with a strong family 
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history (Baker et al., 2006; Mackenzie et al., 2006b). When patients have a 
progranulin mutation, they always have TDP-43 inclusions at autopsy (Josephs et al., 
2007). Similarly, families with mutations in the gene coding for TDP-43 gene have 
been found to develop ALS, but so far such patients have not been found to show 
signs of FTLD (Lagier-Tourenne et al., 2010). In addition, mutations in the valosin 
containing protein gene and the gene encoding the charged multivesicular body 
protein have been reported in a small number of FTLD with TAR-DNA-binding 
protein 43 (TDP-43) positive ubiquitinated inclusions (FTLD-TDP) families (Watts 
et al., 2004; Skibinski et al., 2005). 
 
1.3.5 Charcot-Marie-Tooth disease  
Charcot-Marie-Tooth disease is one of the most commonly inherited disorders of the 
motor and sensory PNS, characterized by muscular atrophy and weakness (reviewed 
in Skre, 1974). CMT is classically subdivided into “primary demyelinating” forms 
(Charcot-Marie-Tooth disease type 1), which are defined by a characteristic 
reduction of nerve conduction velocity and segmental demyelination and 
remyelination, and “primary axonal” forms (Charcot-Marie-Tooth disease type 2) 
that show preservation or mild reduction of nerve conduction velocities and loss of 
axons (reviewed in Patzkó and Shy, 2011). 
 
Mutations in the NEFL gene have been recently reported in many cases of Charcot-
Marie-Tooth disease type 2 (Mersiyanova et al., 2000; De Jonghe et al., 2001; 
Georgiou et al., 2002; Jordanova et al., 2003). Aggregation of NF-L is a common 
pathological hallmark of motor neuron degeneration in Charcot-Marie-Tooth disease 
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type 2 (reviewed in Liu et al., 2011). Three hundred and thrity three Charcot-Marie-
Tooth patients showed six pathogenic mis-sense mutations and one 3-base-pair in-
frame deletion in the NFEL gene (Jordanova et al., 2003). To date, up to 18  NEFL 
mutations have been associated with axonal Charcot-Marie-Tooth disease type 2 
(reviewed in Lupski et al., 2000; Gentil et al., 2012). In cell culture studies, three 
mutations- P22S, P8R, Q333P- in the NFEL gene (Perez-Olle et al., 2005) affected 
the axonal transport of both mutant and non- mutant NFs. 
 
Ageing is the biggest risk factor for most neurodegenerative disorders. For example, 
AD, PD, and ALS all are ageing-related disorders. Neuritic dystrophy and synapse 
loss is recapitulated in mouse models of familial AD (reviewed in Duyckaerts et al., 
2008) and in animal models that naturally develop amyloid pathology with ageing 
(Martin et al., 1991; Cummings et al., 1996). Moreover, an ageing-related decline in 
axonal transport may make axons particularly vulnerable in older individuals 
(Adalbert and Coleman, 2012). Both anterograde and retrograde axonal transport 
proteins decline with age (Adalbert and Coleman, 2012). It is likely then that ageing 
could affect many aspects of cytoskeletal structure, though less is known about how 
ageing affects cytoskeletal function. 
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1.4 TDP-43 
TDP-43 protein is a 414 amino-acid heterogeneous nuclear ribonucleoprotein 
(hnRNP) encoded by the TARDBP gene (Ou et al., 1995), which was originally 
identified as a transcriptional repressor. TDP-43 is an NF-L mRNA binding protein, 
which can stabilize mRNA transcription and is involved in NF mRNA metabolism 
and transport (Strong et al. 2007). An increase in the expression of TDP-43 protein 
has been found in injured young NF-L KO mice (Mossie et al., 2009). 
 
In 2006, TDP-43 was identified as the major ubiquitinated species present in the cells 
of the majority of patients with  ALS and a number of cases of FTLD (Neumann et 
al., 2006). While initially thought to be relatively specific to ALS and FTLD with 
TDP-43 positive ubiquitinated inclusions refered as FTLD-TDP (Neumann et al., 
2006), TDP-43 pathology has now been detected in a number of other 
neurodegenerative diseases, including  AD (Uryu et al. 2008) and PD (Mosca et al. 
2012). TDP-43 mislocalization from the nucleus to the cytoplasm is associated with 
a reduction in NF-L mRNA levels (Caccamo et al., 2009). 
 
Evidence suggsts that neurofilament pathology results from disruption to TDP-43. 
Double immunofluorescence labelling revealed the detection of NF-H protein and 
NF-M protein in inclusion bodies with peripherin in the spinal cord of TDP-
43G348C mutant mice (Swarup et al., 2011a). Moreover, it was found that  NF-L 
protein was downregulated in the spinal cord lysates of TDP-43G348C mutant mice, 
a phenomenon that has also been observed in motor neurons of ALS cases (Wong et 
al., 2000). A decrease in  NF-L protein levels may explain in part the age-related 
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axonal atrophy detected in TDP-43 mutant mice, and may result in a reduction of 
axon conduction velocity similar to that found in NF-L KO mice (Kriz et al., 2000). 
In large animals with long peripheral nerves, this may cause neurological disease. A 
loss of NFs due to a homozygous recessive mutation in the NEFL gene was recently 
identified to cause a severe early-onset axonal neuropathy (Yum et al., 2009).   
 
Human TARDBP is located on chromosome 1p36 and contains 5 coding and 2 
noncoding exons (Rutherford et al., 2008). The TARDBP gene is highly conserved 
in human, mouse, drosophila and C elegans (Wang et al., 2004). TDP-43 binds to 
both DNA and RNA and has multiple functions in transcriptional repression, pre-
mRNA splicing and translational regulation (reviewed in Buratti and Baralle, 2008; 
Wang et al., 2008). Although it is ubiquitously expressed in all tissues, it is highly 
expressed in the brain and kidney (Buratti et al., 2001). It has been found that TDP-
43 protein is ubiquitously expressed in the postnatal mice and rats, but is markedly 
decreased in the adult rodents (Huang et al., 2010). In adulthood, TDP-43 protein 
was even undetectable in peripheral organs including skeletal muscles, liver, and 
kidney, but was constantly expressed at substantial levels in the CNS (Huang et al., 
2010). 
 
1.4.1 Structure   
TDP-43 has two RNA recognition motif (RRM) domains (reviewed in Buratti and 
Baralle, 2008) including RRM1 and RRM2 (both involved in DNA and RNA 
binding and protein–protein interactions), and a carboxy -terminal glycine-rich 
region, a bipartite nuclear localization signal (NLS) and a nuclear export signal 
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(NES) (Figure 1.4). 
 
1.4.1.1 RRM domains 
The RRMs contain two conserved segments: a ribonucleoprotein 2 hexapeptide 
sequence located at the N-terminus of the domain and a ribonucleoprotein 1 
octapeptide consensus sequence (Maris et al., 2005). TDP-43 binding to other TDP-
43 molecules is enhanced by the presence of an intact N-terminus and thus this 
domain may be important in determining TDP-43 aggregation in neurodegenerative 
disease (Zhang et al., 2013). RRM1 domain is the predominant functional RNA 
binding domain for binding to single-stranded RNA (Ou et al., 1995; Buratti et al., 
2001; Wang et al., 2004). RRM2 domain has an atypical RRM-fold with an 
additional β-strand involved in making protein–protein interactions (Kuo et al., 
2009).   
 
1.4.1.2 C-terminal glycine-rich domain 
TDP-43 interacts with other  hnRNP by its C-terminal glycine-rich domain (Buratti 
et al., 2001). Within the nervous system, TDP-43 binds to >6,000 pre-mRNAs 
through this domain and affects the levels of about 600 mRNAs  (Arnold et al., 
2013a). Almost all ALS-associated TDP-43 mutations are dominantly inherited and 
located in the glycine-rich region (Lagier-Tourenne et al., 2010), suggesting that this 
domain drives neurotoxic effects of TDP-43.   
 
  
 
 
 
 
 
 
 
Figure 1.4 The structure of TDP-43 protein (adapted from Lee et al, 2011, review). 
Numerous mutations (shown by short vertical lines) have been linked to sporadic and 
familial forms of ALS and FTLD (these sites are indicated by asterisks).  
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1.4.2 Function 
TDP-43, which is both a DNA and RNA-binding protein, has multiple functions 
(Figure 1.5) in RNA processing, including transcription, pre-mRNA splicing, and 
RNA metabolism (reviewed in Buratti and Baralle, 2008). TDP-43 binds to a large 
proportion of the transcriptome, preferentially localizing to introns (including deep 
intronic sites), 3′ untranslated regions and non-coding RNAs (reviewed in Buratti 
and Baralle, 2008). 
 
1.4.2.1 Transcriptional repression 
TDP-43 can affect mRNA stability and turnover by binding to DNA — in particular, 
single-stranded DNA sequences, resulting in inhibition of transcription through 
unknown mechanisms. For example, TDP-43 was originally identified as a 
transcriptional factor, repressing mRNA levels of HIV-1 gene (Ou et al., 1995), 
cyclin-dependent kinase 6 gene (Ayala et al., 2008), HDAC6 gene (Fiesel et al., 
2010), Futsch gene (the Drosophila melanogaster homologue of MAP1B; Godena et 
al., 2011) and acrosomal protein SP-10 gene (Abhyankar et al., 2007).  
 
1.4.2.2 Pre-mRNA splicing 
TDP-43 is a component of hnRNP complexes that consists of mRNAs, noncoding 
RNAs and RNA-binding proteins (Elvira et al., 2006). HnRNP complexes are known 
to regulate splicing of pre-mRNA species. For example, TDP-43 acts as a splicing 
factor binding to the intron 8/exon 9 junction of the human CFTR gene (Buratti et 
al., 2001), and the intron 2/exon 3 junction of apolipoprotein A2 (APOA2) gene 
  
 
 
 
 
 
 
Figure 1.5 The functions of TDP-43 (modified from Lagier-Tourenne et al., 2010 
and Lee et al., 2011, review). TDP-43 is involved in transcriptional repression (A), 
pre-mRNA splicing (B), RNA metabolism (C), RNA transport and local translation 
(D), miRNA biogenesis (E), and acts as a component of stress granules (F). 
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(Mercado et al., 2005) to inhibit exon splicing. 
 
1.4.2.3 RNA metabolism  
TDP-43 interacts with the RNA-binding protein FUS/TLS (fused in 
sarcoma/translocated in liposarcoma)  and mutations in FUS have been identified as 
a primary cause of familial ALS (Lagier-Tourenne et al., 2010; Ling et al., 2010). 
FUS/TLS is involved in RNA metabolism to regulate transportation, translation and 
degradation of RNA (Colombrita et al., 2009; Vance et al., 2009). 
  
The localization of TDP-43 in RNA granules within neuronal processes suggests that 
TDP-43 is involved in RNA trafficking (Elvira et al., 2006; Wang et al., 2008). Thus 
the mRNA binding properties of TDP-43 may facilitate mRNA trafficking from the 
nucleus to the cytoplasm as part of the biological machinery that regulates mRNA 
metabolism (Liu-Yesucevitz et al., 2010).  
 
TDP-43 and FUS/TLS may additionally play roles in microRNA (miRNA)  
biogenesis, as they associate with drosophila and mouse miRNA processor 
complexes to degrade or translationally silence mRNA (Feiguin et al., 2009; Ling et 
al., 2010). Knockdown of TDP-43 alters the level of several miRNAs (Buratti et al., 
2010). Mutations in TDP-43 and FUS/TLS lead to abnormal protein expressions 
(reviewed in Verma et al., 2011). 
 
TDP-43 and FUS/TLS are also integral components of RNA stress granules under 
stress conditions (Wang et al., 2008; Colombrita et al., 2009; Lagier-Tourenne et al., 
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2010).  The role of these TDP-43-positive stress granules remains unknown, but they 
were proposed to mediate the stabilization and transport of the NF-L mRNA to the 
injury site for local translation of NF-L protein required for axonal repair (Strong et 
al., 2007; Moisse et al., 2009). 
 
1.4.3 Pathology of TDP-43  
1.4.3.1 Genetic mutation  
The list of genes that are associated with either ALS or FTLD include TDP-43 
(Gitcho et al., 2008; Sreedharan et al., 2008; Yokoseki et al., 2008), FUS 
(Kwiatkowski et al., 2009), copper/zinc superoxide dismutase (Deng et al. 1993), 
UBLN2 (Deng et al., 2011), optineurin (Maruyama et al. 2010), granulin (Baker et 
al., 2006; Cruts et al., 2006), valosin containing protein (Watts et al. 2004), ataxin 2 
(Elden et al., 2010), sigma non-opioid intracellular receptor 1 (Al-Saif et al., 2011; 
Luty et al., 2010) and C9ORF72 (Dejesus-Hernandez et al., 2011; Renton, 2011). 
Despite the variety of genes that are implicated in ALS and FTLD, there is 
remarkable homogeneity in terms of downstream pathology: nearly every patient 
with ALS or FTLD that is linked to a genetic mutation exhibits TDP-43 pathology 
(reviewed in Cook et al., 2008 and Lee et al., 2011) 
 
Pathogenic mutations in the TDP-43 gene (Figure 1.4) have been found in sporadic 
and familial ALS (Gitcho et al., 2008; Sreedharan et al., 2008; Yokoseki et al., 2008; 
reviewed in Al-Chalabi et al., 2012), FTLD (Winton et al., 2008), and recently in PD 
(Mosca et al., 2012), providing evidence of a direct link between TDP-43 
abnormalities and neurodegeneration. Approximately 2–3% of patients affected by 
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sporadic and familial forms of ALS carry specific mis-sense mutations in the C-
terminus of TDP-43 (Gitcho et al., 2008; Kabashi et al., 2008; Kuhnlein et al., 2008; 
Rutherford et al., 2008; Sreedharan et al., 2008; Van Deerlin et al., 2008; Yokoseki 
et al., 2008; Lemmens et al., 2009).  
 
1.4.3.2  TDP-43 cytoplasmic inclusions in FTLD-TDP and ALS   
Normally, TDP-43 protein is localized to the nucleus. However, ubiquitin-positive 
TDP-43 immunoreactive cytoplasmic inclusions in neurodegenerative disorders are 
present in the cytoplasm as well as TDP-43 inclusion in the nucleus (Neumann et al., 
2006; Winton et al., 2008). Pathologic TDP-43 in the cytoplasm is present with 
abnormal posttranslational modifications, including phosphorylation, ubiquitination 
and proteolytic cleavage (reviewed in Lee et al., 2011). The reason that this occurs is 
not known. One possible mechanism is that the transport of TDP-43 back into the 
nucleus is faulty. Researchers have explored the factors that regulate the transport of 
TDP-43 and found that a TDP-43 nuclear transport factor (called celluar apoptosis 
susceptibility) is deficient in FTLD and ALS patients (Nishimura et al., 2010). In 
addition, it has been found that sequestration into polyglutamine aggregates causes 
TDP-43 to be cleared from the nucleus and become detergent-insoluble (Fuentealba 
et al., 2010).   
 
The cytoplasmic ubiquitin-positive inclusions are present in the lower motor neurons 
and, less frequently, upper motor neurons of ALS patients (Leigh et al., 1991; Ince et 
al., 1998). In cases of ALS with dementia, and in some ALS patients with minor 
cognitive changes, ubiquitin-positive inclusions are also present in other brain 
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regions including the extramotor neocortex and hippocampus (Okamoto et al., 1991; 
Wightman et al., 1992; Mackenzie and Feldman, 2005; Geser et al., 2008). In ALS, 
TDP-43 inclusions were predominantly localized to the neuronal cytoplasm (Van 
Deerlin et al. 2008; Giordana et al. 2010), dystrophic neurites (Neumann et al., 
2006), and are also found in the glial cytoplasm (Van Deerlin et al., 2008; Giordana 
et al., 2010).  
 
The relative amount of inclusions in different cellular structures differs among the 
FTLD-TDP types (Josephs et al., 2009; Mackenzie et al., 2006a). For example, Type 
1 is associated with widespread cortical and subcortical neuronal cytoplasmic 
inclusions, dystrophic neurites and neuronal intraneuronal inclusions, while Type 2 
has predominantly dystrophic neurites in the CTX and Pick-body like neuronal 
cytoplasmic inclusions in the dentate fascia, amygdala and basal ganglia, and Type 3 
has mainly neuronal cytoplasmic inclusion in medial temporal lobe structures and in 
cases with motor neuron disease, neuronal cytoplasmic inclusions in motor neurons 
(reviewed in Cook et al., 2008). 
 
TDP-43 cytoplasmic inclusions observed in cell culture models of ALS appear to 
correspond to stress granules, which are cytoplasmic compartments composed of 
RNA and proteins, formed under stressful conditions to consolidate mRNA and 
prevent further translation of protein (Chernov et al., 2009; Colombrita et al., 2009). 
However, the mechanisms by which TDP-43 might associate with stress granules are 
unknown. In addition, it remains unclear whether aggregation of TDP-43 into 
inclusions is detrimental (Hanson et al., 2010), or whether cellular distress is caused 
by cytoplasmic expression of TDP-43 or by loss of TDP-43 from the nucleus 
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(reviewed in Lee et al., 2011). 
 
1.4.3.2.1 Phosphorylation 
Aberrant phosphorylation of full-length TDP-43, resulting in a product of 45 kDa, 
was first observed in FTLD-U and ALS brains (Neumann et al., 2006). Using rabbit 
polyclonal antibodies against 36 of the 64 potential phosphorylation sites within 
TDP-43, Hasegawa et al. (2008) determined that five Serine residues localized at the 
C-terminal extremity of TDP-43 were specifically phosphorylated (S379, S403, 
S404, S409, S410). One of the kinases responsible for the abnormal phosphorylation 
of TDP-43 may be casein kinase 1 (Hasegawa et al., 2008). Phosphorylation-
dependent antibodies to pS409/S410 label all types of abnormal inclusions, such as 
dystrophic neurites, neuronal cytoplasmic and nuclear inclusions, as well as glial 
cytoplasmic inclusions, in various TDP-43 proteinopathies (Hasegawa et al., 2008). 
Importantly, antibodies against pS409/S410 fail to detect non-pathologic nuclear 
TDP-43 by immunohistochemistry (Hasegawa et al., 2008), providing further 
support that phosphorylation is a disease-specific phenomenon. By comparing the 
levels of labelling of “preinclusions” by these antibodies described above with anti-
ubiquitin antibodies, it has also been possible to determine that phosphorylation 
precedes ubiquitination (reviewed in Segref and Hoppe, 2009). Phosphorylated TDP-
43 proteins exhibit a longer half-life than non-phosphorylated proteins, suggesting 
that phosphorylation may inhibit ubiquitin proteasome system (UPS)-mediated 
degradation and thus contribute to aggregate formation (Zhang et al., 2010). 
Alternatively, as TDP-43 phosphorylation is associated with TDP-43 insolublility, it 
remains possible that aggregation may render TDP-43 C-terminal fragments less 
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vulnerable to proteasome-mediated degradation and that phosphorylation is merely a 
marker of aggregation (reviewed in Lee et al., 2011).  
 
1.4.3.2.2 Ubiquitination 
 
The UPS is the major eukaryotic protein degradation pathway, and plays a very 
important role in normal neuronal development, as reviewed recently by Segref and 
Hoppe (2009). At present, the residues involved in TDP-43 ubiquitination are still 
unknown although they presumably occur in  the lysine residues in TDP-43. 
Inhibition of the UPS leads to increased levels of phosphorylated TDP-43 aggregates 
in cultured cells (Winton et al., 2008). Moreover, disruption of the UPS might 
contribute to increased levels of ubiquitinated TDP-43 in ALS and FTLD-TDP 
(reviewed in Lee et al., 2011). 
 
1.4.3.2.3 C-Terminal fragments of TDP-43  
 
25 and 35 kDa C-terminal TDP-43 fragments lacking NLS, are detected in the 
neurons of ALS patients and are normally absent from neurons from non-ALS cases 
(Igaz et al., 2011). It has been shown that these fragments are unable to regain access 
to the nucleus, contributing to their accumulation in the cytoplasm (reviewed in Lee 
et al., 2011). It has been suggested that these fragments are produced by proteolytic 
cleavage and derive from the activation of caspase-dependent cleavage (Zhang et al., 
2007). In cell lines and primary rat neuronal cultures, the introduction of tandem 
repeats carrying the C-terminal Gln/Asn-rich region (residues 321-366) of TDP-43 
can trigger the formation of phosphorylated and ubiquitinated aggregates (Budini et 
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al., 2013) 
 
1.4.3.3 TDP-43 in AD 
While TDP-43 pathology was first described in ALS and FTLD-TDP, it has now 
been detected in a number of other neurodegenerative diseases, such as AD 
(reviewed in Cook et al., 2008; Wilson et al., 2011). TDP-43 neuronal and glial 
inclusions have been estimated to occur in approximately 25-30% of sporadic AD 
cases (Uryu et al., 2008; Amador-Ortiz et al., 2007b; Kadokura et al., 2009), but 
perhaps lower (14%) in familial AD and Down’s syndrome (Lippa et al., 2009). 
Pathologic forms of TDP-43, such as abnormal phospho-epitopes (Arai et al., 2009) 
or carboxyl-terminal epitopes, were detected in limbic regions of the brain, including 
the hippocampus, amygdala and adjacent cortices of AD patients (Amador-Ortiz et 
al., 2007a; Amador-Ortiz et al., 2007b; Uryu et al., 2008). 
 
1.4.4  Overexpression and loss of TDP-43 
It has been reported that the mRNA and protein expression of  TDP-43 and NF-κB 
p65 are higher in the spinal cords of ALS patients than healthy individuals (Swarup 
et al., 2011b). Overexpression of the normal human TDP-43 gene has been shown to 
cause neurodegeneration in transgenic organisms from flies to mice (Li et al., 2010). 
This implies that aberrant accumulation of TDP-43 is toxic to vulnerable neurons and 
can cause ALS-like phenotypes at the cellular and organismal level (Johnson et al., 
2009; Wegorzewska et al., 2009). Recent studies have identified several new 
molecular constituents of ALS-linked cellular aggregates, including FUS, TDP-43, 
OPTN, UBQLN2 and the translational product of intronic repeats in the gene 
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C9ORF72 (Blokhuis et al., 2013). Additionally, overexpression of WT or mutant 
TDP-43 in transgenic mice also can cause a neural degeneration of  motor neurons 
without cytoplasmic TDP-43 aggregates (Wegorzewska et al., 2009; Stallings et al., 
2010; Wils et al., 2010; Xu et al., 2010), which suggests an up-regulation of TDP-43 
without TDP-43 cytoplasmic aggregates also can contribute to neurodegeneration by 
triggering pathogenic pathways via NF-κB activation (Swarup et al., 2011b). 
 
Depletion of mouse TDP-43 in motor neurons also leads to an ALS-like 
neurodegenerative phenotype (Wu et al., 2010). In addition, overexpression and 
knockdown of TDP-43 can cause swimming defects in zebrafish (Kabashi et al., 
2010). Both gain and loss of drosophila TDP-43 (dTDP-43) resulted in pupal 
lethality and reduced adult viability, impaired larval locomotor activity, axonal loss, 
and altered synaptic boutons (Feiguin et al., 2009; Li et al., 2010; Ritson et al., 2010; 
Lin et al., 2011; Wang et al., 2011). Both up- and down-regulated dTDP-43 directly 
and dramatically increased the expression of the neuronal MAP (Map205), resulting 
in cytoplasmic accumulations of the ecdysteroid receptor and a failure to switch 
Ecdysteroid receptor-dependent gene programs from a pupal to adult pattern 
(Vanden Broeck et al., 2013). 
 
As decribed above, the loss-of-function and overexpression genotypes of TDP-43 
were generated to study their effect on the transcriptome of the CNS, by using 
Drosophila melanogaster as a model. Using massively parallel sequencing, it was 
found that loss of TDP-43 results in widespread gene activation and altered splicing 
(Hazelett et al. 2012). Conversely, overexpression of TDP-43 resulted in decreased 
gene expression–a finding contrary to previous studies that indicated both loss-of-
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function and over expression may cause ALS (Hazelett et al., 2012).  Abnormal 
TDP-43 deposits have been found in the brains of cognitively normal elderly subjects 
(Arnold et al., 2013b). Additionally, NF disorganizations have been found in TDP-43 
G348C mutant mice (Swarup et al., 2011a). However, It remains unclear if  NF 
pathological alterations can also cause TDP-43 abnormalities and how this is 
affected by ageing. 
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1.5 Myelination 
1.5.1 General introduction to myelination 
Myelination is one of the fundamental biological processes in the development of 
vertebrate nervous system (Morell, 1984). Early ultrastructural investigations 
demonstrated that myelinated fibers develop stereotyped ratios between axon caliber, 
myelin thickness, and internodal distances (reviewed in Bradl and Lassmann, 2010). 
Myelination is associated with increases in axonal caliber, the latter which is 
important functionally as a determinant of neuronal conduction velocity (Arbuthnott 
et al., 1980). With increasing axon calibers, myelin sheaths are proportionally thicker 
and longer. That means, as axons increase in diameter, there is a correlated increase 
in sheath thickness (Windebank et al., 1985). G-ratio (axon diameter/fibre diameter; 
Rushton, 1951) is widely utilized as a functional and structural index of optimal 
axonal myelination (Chomiak and Hu, 2009). Myelin thickeness and node spacing is 
highly regulated and thought to be cotrolled by signalling beteween the axon and the 
oligodendrocytes (reviewed in Chrast et al., 2011). However, it is unclear how 
decreased axon calibre, which  is found in many diseases, affects myelination. 
 
Phosphorylation of NF is regulated by myelination (Starr et al., 1996). This is 
evidenced by the observations that NF phosphorylation is decreased in 
dysmyelinating mutant Trembler mice (de Waegh et al., 1992). In addition, axonal 
caliber is influenced by NF number (Hoffman and Griffin, 1992; Ohara et al., 1993; 
Eyer and Peterson, 1994) and NF spacing (Friede and Samorajski, 1970; Hoffman 
and Griffin, 1992). Disturbance of myelination is found to be associated with 
progression in many neurological diseases (Lazzarini, 2004). However, it is not clear 
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how this relates to NF alterations and changes in the axon. 
 
1.5.2  Functions of myelination 
The myelin sheath is an electrically insulating layer and helps to increase the speed 
by which information travels along the nerve (Lazzarini, 2004). Myelin sheath 
facilitates conduction while conserving space and energy (Waxman and Bangalore, 
2004). It increases the transmission speed of the axons and also reduces ongoing 
energy consumption. Demyelinated axons have increased numbers of active 
mitochondria, suggesting higher energy consumption (Andrews et al., 2006; 
Campbell et al., 2011). In additon, myelination plays important roles in axonal 
transport (Edgar et al. 2004) and microtubule stability (Kirkpatrick et al., 2001). For 
example, the stability of MTs is drastically reduced in shiverer mice, a mouse line 
with a deletion in the myelin basic protein (MBP) gene (Kirkpatrick et al., 2001).  
 
Myelinating oligodendrocytes are crucial for long-term axonal survival by providing 
metabolic support to the axons (Lee et al., 2012). Glucose is the primary energy 
source in the adult brain, however, when glucose levels are low, lactate from the 
oligodendrocytes can support the energy needs of neurons (Funfschilling et al. 2012; 
Lee et al. 2012). Monocarboxylate transporter 1 (MCT1), the most abundant lactate 
transporter in the CNS, is highly enriched in the oligodendrocytes (Funfschilling et 
al., 2012). Disruption of this transporter produces axon damage and neuron loss in 
animal and cell culture models (Lee et al., 2012). Reduced MBP and MCT1 
expression are found in  the ALS mouse model (Philips et al., 2013). Reduced 
expression of MCTs is one mechanism by which oligodendrocytes produce 
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neurotoxicity in patients and mouse models of ALS (Lee et al., 2012). 
 
Demyelination can cause axonal atrophy. For example, mice with a null mutation of 
the myelin-associated glycoprotein (MAG) gene have a chronic atrophy of 
myelinated PNS axons that results in paranodal myelin tomaculi and axonal 
degeneration (Yin et al., 1998). However, loss of the structural proteins of compact 
PNS myelin-MBP does not lead to axonal atrophy (Yin et al., 1998). 
 
1.5.3  Structure of myelin 
In both CNS and PNS, myelination is a complex process in which glial cells extend 
processes that enwrap axons and generate compact myelin (Lazzarini, 2004). 
Oligodendrocytes are the glial cells that produce myelin by wrapping their process-
extension of the plasma membrane  around 6–10 different axons in the CNS 
(reviewed in Baumann and Pham-Dinh, 2001). In the CNS, myelination is 
characterized by proliferation and differentiation of oligodendrocyte precursors and 
accumulation of myelin-associated proteins and lipids (reviewed in Laule et al., 
2007). In the PNS, Schwann cells enwrap single axons around segments of the axon, 
leaving small gaps in-between called nodes of Ranvier (Lazzarini, 2004). CNS and 
PNS myelin serve comparable functions and are superficially similar, but they differ 
in embryonic origin, genetics, composition, and ultrastructure (reviewed in Chrast et 
al., 2011). 
 
1.5.4 Characteristic composition of myelin 
Both CNS and PNS myelin is composed of 40% water, lipids (70-85% of the dry 
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mass) and protein (15-30% of the dry mass) (Martenson, 1992). The accepted view 
of membrane structure is that of a lipid bilayer with integral membrane proteins 
embedded in the bilayer and other extrinsic proteins attached to one surface or the 
other by weaker linkages (Martenson, 1992). Proteins and lipids are asymmetrically 
distributed in this bilayer, with only partial asymmetry of the lipids (reviewed in 
Laule et al., 2007). Figure 1.6 is the proposed molecular architecture of the layered 
membranes of compact myelin (reviewed in Laule et al., 2007).  
 
1.5.4.1  Myelin basic protein (MBP) and proteolipid protein (PLP) 
MBP and PLP are the two principle proteins in compact myelin of the CNS (Quarles 
et al., 2006). As an essential component of CNS myelin,  MBP plays important roles 
in myelination in the CNS (Campagnoni et al., 2001). MBP comprises up to 40% of 
oligodendrocyte protein synthesis but is much lower in PNS (Quarles et al., 2006). 
The gene for MBP is on human chromosome 18 (Campagnoni et al., 2001).  MBP 
genes from a number of species are highly conserved, and the gene can be 
alternatively spliced  (Campagnoni et al., 2004). The  MBP gene has seven exons, 
with the full length MBP (21.5 kDa) containing all seven exons, although this protein 
is one of the minor MBP proteins in myelin (Campagnoni et al., 2004). Exons 2, 5B 
and 6 are present or absent in four other MBP proteins found in myelin (Campagnoni 
et al., 2004). The most abundant MBP in human myelin contains exons 1B, 3, 4, 6 
and 7 (18.5 kDa MBP), whereas, in rodent myelin, both the 18.5 kDa MBP and a 14 
kDa MBP containing exons 1B, 3, 4, 5 and 7 are the most abundant (Quarles et al., 
2006). Two different minor MBPs of approximately 17 kDa exist, which are encoded 
by exons 1B, 2, 3, 4, 5B and 7 or 1B, 3, 4, 6 and 7 respectively (Aruga et al., 1991). 
  
 
 
 
 
Figure 1.6  The CNS myelin sheath surrounding an axon with inset depicting close 
up of bilayer, including myelin basic protein (MBP), PLP (proteolipid protein), 2', 3'-
cyclic nucleotide 3'-phosphodiesterase (CNPase), and MAG (adapted from Laule et 
al, 2007, review). 
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A diagrammatic representation of some of these alternative splicing schemes is 
presented in Figure 1.7 (Quarles et al., 2006). The ratio of the MBP changes with 
development, with more 14 kDa MBP found in mature rodent tissue (Campagnoni et 
al., 2004). MBP KO mice have showed markedly reduced MBP levels and 
incomplete CNS myelin sheath formation, leading to a progressive disorder 
characterized by tremors, seizures, and early death (Rosenbluth, 1980; Shen et al., 
1985; Seiwa et al., 2002; Martin et al., 2006).  
 
PLP is an integral membrane protein with four trans-membrane domains, comprising 
50% of total myelin proteins (Lazzarini, 2004). PLP plays an important role in the 
formation or maintenance of the multilamellar structure of myelin (Quarles et al., 
2006). Moreover, PLP is an insulator which greatly increases the velocity of axonal 
impulse conduction (Lazzarini, 2004). Oligodendrocytes lacking PLP are still 
capable of myelinating axons, although physical stability of myelin decreases, as 
PLP is responsible for the compaction of myelin sheaths (Boison et al., 1995). In 
human, point mutations in PLP are the cause of Pelizaeus-Merzbacher disease, a 
neurologic disorder of myelin metabolism (reviewed in Koeppen and Robitaille, 
2002). 
 
PLP and MBP differ greatly in character and sites of synthesis (reviewed in Kalwy 
and Smith, 1994). PLP is synthesized at the rough endoplasmic reticulum, 
transported to the Golgi by vesicular traffic, processed through the Golgi apparatus, 
and then transported to the myelin membrane. It is not entirely clear how PLP 
reaches its final destination, the myelin sheath (Lazzarini, 2004). MBP mRNA is, 
however, directly translocated to the ends of the cell processes, where it is translated 
  
 
 
 
 
 
Figure 1.7 The amino acid sequences corresponding to the various mouse MBPs are 
encoded by a gene containing at least 11 exons (separated by introns – DNA regions 
whose base sequence does not code directly for proteins) (adapted from Quarles et 
al., 2006). 
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on free ribosomes and incorporated into the membrane (Brophy et al., 1993).  
 
Although proteins responsible for compaction of CNS and PNS myelin are well 
characterized, less is known about proteins mediating axon–glial cell interactions in 
either CNS or PNS. 
 
1.5.4.2   2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) 
As an abundant protein in both CNS and PNS myelin, CNPase is found exclusively 
in the cytoplasm of oligodendrocytes and Schwann cells (Braun et al. 2004). The 
enzyme is distributed in single and double loose wraps of non-compact myelin 
(Quarles et al., 2006). Developmentally, this enzyme appears early in 
oligodendrocytes, earlier than most other myelin proteins (Kursula, 2008). CNPase 
continues to be expressed at high levels in oligodendrocytes and Schwann cells of 
adult animals. In various diseases, neurological mutants, and in experimental 
conditions in which myelin is reduced, CNPase is one of the earlier proteins to be 
severely reduced from the myelin (Braun et al., 2004). The enzyme itself exists in 
two forms in most species (three in mouse) with molecular weights of 48 and 46 kDa 
on Sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), referred to as CNP2 
and CNP1, respectively (Braun et al., 2004). 
 
1.5.4.3  Myelin-associated glycoprotein (MAG) 
MAG is a member of the I-type lectin subgroup of the Ig gene superfamily (Arquint 
et al., 1987; Lai et al., 1987; Salzer et al., 1987). In the CNS, MAG is present in the 
periaxonal membranes of myelin-forming oligodendrocytes, but it is also present in 
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the Schwann cell membranes of the Schmidt–Lanterman incisures, paranodal loops 
and the outer mesaxon (reviewed in Quarles, 2002; Georgiou et al., 2004). MAG was 
initially considered a potential receptor for an axonal ligand important to the 
initiation and progression of myelination (reviewed in Trapp, 1990). MAG is one of 
several neural proteins that inhibit neurite outgrowth in tissue culture and axonal 
regeneration in vivo (McKerracher et al., 1994; Mukhopadhyay et al., 1994). 60% of 
axonal growth cones of postnatal day 1 hippocampal neurons collapsed when they 
encountered polystyrene beads coated with recombinant MAG (rMAG)  (Li et al., 
1996). Mice with a null mutation of the MAG gene have a chronic atrophy of 
myelinated PNS axons that results in paranodal myelin tomaculi and axonal 
degeneration (Yin et al., 1998). These data suggest that MAG directly or indirectly 
modulates the axonal cytoskeleton and structural integrity.  
 
1.5.5   Myelination and NFs 
Although it has been well documented that NFs are essential for axons to achieve 
normal calibers (Cleveland et al., 1991) and that NFs are highly phosphorylated in 
myelinated domains (de Waegh et al., 1992; Mata et al., 1992; Garcia et al., 2003; 
Rao et al., 2003), the effects of altered axonal NF on myelin thickness, structure and 
composition remain unclear. 
 
In HM-DKO mice, which lack genes encoding NF-H and NF-M subunits, NF 
content of large myelinated axons of the CNS was decreased in the absence of 
changes in myelin thickness and volume (Jacomy et al., 1999). In addition, mice null 
for NF-H achieved normal axonal calibers but conducted action potentials at 
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relatively reduced speeds (Rao et al., 1998; Zhu et al., 1998). In shiverer mutant 
mice, which lack functional MBP, CNS myelin sheath formation was markedly 
reduced but NF content was normal (Dyakin et al., 2010). Absence of MAG was 
correlated with reduced axonal calibers, decreased NF spacing, and reduced NF 
phosphorylation (Yin et al., 1998). These results show that although NFs play a 
fundamental role in axon radial growth, they do not act alone to determine the final 
caliber of axons (Kriz et al., 2000).  
 
NF-L protein is important for the maintenance of normal morphology of myelinated 
axons. Morphological distortion and degeneration in myelinated axons were 
observed in the white matter region of spinal cord  in 2- and 6-month old NF-L KO 
mice (Wu et al., 2008). The diameter of axons of upper motor neurons of NF-L KO 
mice decreased significantly while the thickness of their myelin sheath increases 
remarkably (Wu et al., 2008).   
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1.6 NF transgenic mice  
To clarify the role of NFs in neurodegenerative diseases, the genes encoding the 
major NF proteins have been knocked out in mice as well as over-expressed (Table 
1.1).  
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Table 1.1 Transgenic mouse models for NF subunit knockout or overexpression 
(adapted from reviewed in Liu et al., 2004a). 


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1.6.1 NF  knockout (KO) mice 
Mice lacking NF proteins exhibit various degrees of reductions in axonal caliber and 
changes in spacing between the NFs (reviewed in Liem and Messing, 2009). None of 
the KO mouse models for NF genes developed gross developmental defects of the 
nervous system, which indicates that NFs are generally not required for axogenesis, 
or that other cytoskeletal elements may compensate for the absence of NFs. 
However, it is noteworthy that substantial loss of motor axons was detected in mice 
lacking NF-L, NF-M, or both NF-M and NF-H proteins (Zhu et al., 1997; Elder et 
al., 1998a, b, 1999a, b; Jacomy et al., 1999). 
 
1.6.1.1 NF-L KO mice 
Zhu et al. (1997) was the first group to generate NF-L KO mice, by using the 
technique of homologous recombination in embryonic stem cells in C57BL/6 mouse 
genetic backgrounds  (Zhu et al., 1997). The NF-L KO mice developed normally and 
did not exhibit overt phenotypes (Zhu et al., 1997). However, NF-L KO mice have 
mild sensorimotor dysfunction and spatial memory deficits, but without overt signs 
of paresis at 6 months of age (Dubois et al., 2005). In the spinal cord of NF-L KO 
mice, there was decreased axon caliber, abnormal axon conductance and delayed 
maturation of regenerating myelinated axons (Zhu et al., 1997). Myelinated axons in 
NF-L KO mice exhibited a reduction of up to 50% in conduction velocity (Kriz et 
al., 2000). NF-L KO mice had a scarcity of IF structures and exhibited axonal 
hypotrophy (Zhu et al., 1997), confirming the importance of NF-L in IF assembly 
and in regulating axonal calibre (reviewed in Julien et al., 1999). By deleting NF-L, 
onset and progression of disease caused by familial ALS-linked SOD1 mutant G85R 
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are significantly slowed, while levels of NF-M and NF-H  are markedly reduced in 
axons but are elevated in motor neuron cell bodies (Williamson et al., 1998). These 
results would be consistent with a requirement for heterodimerization of NF-L to 
NF-M or NF-H subunits to achieve efficient translocation into the axonal 
compartment (Zhu et al., 1997). In the mutant quiver quail model, the absence of NF-
L leads to the “quivering” phenotype (Toyoshima et al., 2000). Recently, the first 
human case of a homozygous recessive mutation in NF-L has been shown to result in 
a severe, early-onset peripheral neuropathy with reduced numbers of myelinated 
fibers (Yum et al., 2009). 
 
1.6.1.2 NF-H KO mice 
Only a slight reduction in the caliber of myelinated axons has been found in the 
ventral roots of NF-H KO mice (Rao et al., 1998; Zhu et al. 1998), whereas the NF-H 
KO mice described by Elder et al. (Elder et al.1998b) exhibited a more pronounced 
reduction in the caliber of axons. These discrepancies may possibly be attributable to 
differences in the mouse genetic backgrounds. The mice from the Rao group (Rao et 
al., 1998) and from Julien’s group  (Zhu et al., 1998) were on a C57BL/6 
background, whereas Elder et al. (Elder et al., 1998b) analyzed NF-H KO mice on a 
129J background. However, the combined results suggest a relationship between the 
radial growth of axons lacking NF-H and the degree of compensatory changes in 
levels and/or phosphorylation of NF-L and NF-M subunits (reviewed in Julien et al., 
1999). 
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1.6.1.3 NF-M KO mice  
The lack of NF-M has a more severe effect than disruption of NF-H on the radial 
growth of large myelinated axons (Elder et al., 1998a, 1999a, b; Jacomy et al., 1999), 
which indicates that NF-M protein is more important than NF-H as mediator of 
axonal growth. The absence of NF-M did not cause any phenotypic changes in mice 
but caused an increase in NF-H level and a decrease in NF-L level (Elder et al., 
1998a).  The decrease of NF-L levels in NF-M KO mouse caused axonal NF content 
decrease of more than 50%, resulting in axonal atrophy (Elder et al., 1998a; 1999a). 
However, the axonal atrophy in skeletal muscles was not accompanied by significant 
axonal loss or anterior horn cell pathology (Elder et al., 1999a).  
 
1.6.1.4 Double or triple NF KO mice 
NF-M and NF-H double KO mice developed atrophy in ventral and dorsal roots as 
well as a hind limb paralysis with aging (Jacomy et al., 1999). Moreover, the 
disruption of both NF-M and NF-H subunits caused the sequestering of unassembled 
NF-L proteins in neuronal perikarya resulting in a reduction of axonal caliber 
equivalent to NF-L KO mice (reviewed in Lariviere and Julien, 2004).  
 
A decrease of NF content in triple heterozygous KO mice (NF-L KO; NF-M KO; 
NF-H KO) shifted the calibers of large L5 ventral root axons from 5–9 to 1–5 µm 
(Nguyen et al., 2000). 
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1.6.2 Overexpression of NF in mouse models 
Overexpression of NFTPs in mice can lead to neuronal dysfunction. NF inclusions, 
which are major hallmarks of a number of different neurodegenerative diseases, can 
be induced by over expression of mouse and human NFTPs in transgenic mice. 
Levels of expression may be important in determining the severity of the phenotypes 
(reviewed in Liem and Messing, 2009). NF accumulations in these mouse models 
can be reduced by an increase of NF-L levels (Kong et al., 1998; reviewed in Julien 
et al., 1998). Increasing the ratio of NF-L to NF-H and NF-M can restore the radial 
growth of axons (Marszalek et al., 1996; Julien et al., 1998) and normal dendritic 
trees in motor neurons (Kong et al., 1998). These studies prove the importance of 
subunit stoichiometry for correct NF protein assembly and transport (reviewed in 
Julien et al., 1999). 
 
1.6.2.1 NF-L overexpressing mice 
Four-fold overexpression of mouse NF-L causes striking ALS-like pathology, 
including intensive NF aggregation, neuronal degeneration and severe muscle 
atrophy (Xu et al., 1993). In addition, most of the mice died before 3 weeks post-
natally with only 1/3 to 2/3 the body weight of normal mice (Xu et al., 1993). These 
studies confirm that NF aggregation in mice could directly cause abnormality of 
motor neurons (reviewed in Liu et al., 2004a). 
 
1.6.2.2 NF-M overexpressing mice 
With ~2-fold increase in expression of NF-M level in the mice, accumulations of 
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NFs, due to a block of transport of NFs into the axon, have been found in cell bodies 
and axons of ventral horn motor neurons, accompanied by decreased axonal caliber, 
but without neuronal degeneration and an overt functional phenotype (Cote et al., 
1993; Collard et al., 1995).    
 
1.6.2.3 NF-H over expressing mice 
Overexpression of NF-H not only impairs NF transport into the axon resulting in 
severe perikaryal accumulation of NFs and proximal axonal swellings in motor 
neurons (Marszalek et al., 1996), but also inhibits dendritic arborization (Kong et al., 
1998). However, NF-H over expression does not result in any overt phenotype, or 
neuron degeneration/loss (Marszalek et al., 1996). 
 
In summary, these mouse models provide solid evidence for NF function:  
expression of NF-L is responsible for NF assembly, and NF-M/H subunits are 
required for NF assembly in vivo; NF-M is more critical for axonal growth than NF-
H, and the latter may be working as a key factor for NF interaction with other 
cytoskeletal polymers. Transgenic mice such as NF-L KO mice, NF-H KO mice and 
NF-M or NF-H overexpression mice, appear to be able to survive without a 
substantial overt phenotype although alterations in NF can lead to cytoskeletal 
pathological changes similar to that seen in a number of neurodegenerative diseases 
(Table 1.1). However, little is known about how alterations to NFs are affected 
during ageing. In addition, links between NF alterations and other pathological 
features of neurodegenerative disease are unclear. 
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1.7   Project Aims 
Despite an accumulating literature regarding the structure and function of NFs, the 
roles of NFs in neurodegenerative disease are currently poorly understood. Many 
studies modeling NF abnormalities in mice have been reported, in order to 
investigate the contribution to pathology associated with neurodegenerative disease. 
However, few of these studies have looked at the role of NFs with respectto 
apdaptive changes in the neuronal cytoskeleton, as well as in relation to myelination 
and NF RNA-binding proteins, in ageing or related neurodegenerative diseases. 
Therefore, this thesis will seek to determine the consequences of the absence of NFs 
on the adaptive capacity of the neuronal cytoskeleton in adulthood and ageing, the 
consequences on myelination and also on NF RNA-binding proteins that have been 
implicated in a number of neurodegenerative diseases. 
   
AIM 1: To investigate the consequences of the absence of NF-L on the adaptive 
capacity of the neuronal cytoskeleton in adulthood and ageing  !
The NF-L subunit is considered as an obligate subunit polymer for the assembly of 
NFTPs into neuronal IFs (Carter et al., 1997). These triplet subunits are co-expressed 
in a subset of neurons throughout the brain, including a subgroup of neo-cortical 
pyramidal cells in many species (Vickers and Costa, 1992; Sampson et al., 1997; 
Kirkcaldie et al., 2002; Paulussen et al., 2011). Previous studies have shown that 
deletion of NF-L substantially reduced axonal NFs and resulted in NF accumulation 
which have been described in human neurodegenerative disease (Zhu et al., 1997; 
Wong et al., 2000;). However, the consequences of the absence of NFs on the 
adaptive capacity of the neuronal cytoskeleton in adulthood and ageing are not 
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known. To better understand this, this thesis has examined cytoskeletal proteins 
expression including phosphorylated and dephosphorylated NFs, NF-M and  INT, 
actin, MAP2 and tubulin in the CTX of NF-L KO mice in adulthood and ageing. 
Additionally, this thesis has examed the density or cytoarchitectural of 
calretinin(CR)-immunolabelled non-pyramidal cells in the CTX of NF-L KO mice. 
 
AIM 2: To determine the consequences of the absence of NF-L on NF RNA-
binding protein--TDP-43   
Recently, TDP-43, an NF-L mRNA binding protein (Strong et al., 2007), has been 
pathologically associated with a number of neurodegenerative diseases of ageing, 
such as ALS and AD (Wilson et al., 2011; Lee et al., 2012). However, mechanisms 
of TDP-43 pathogenesis are unknown. As TDP-43 is known to bind to NF-L mRNA, 
this thesis has investigated the consequences of the deficiency of NFs on TDP-43 
protein. Therefore, immunohistochemical and quantitative Western blot approaches 
have been used to examine the changes of TDP-43 expression and distribution in the 
brains and spinal cords of NF-L KO mice at 10 weeks and 12 months. Additionally, 
this thesis has examed the the expression of phosphorylated TDP-43 in the brains 
and spinal cords of aged NF-L KO mice. 
 
AIM 3 : To determine the consequences of the deletion of NF-L on myelination  
NFs have a critical role in myelination by regulating axonal diameter. Additionally, 
MBP and PLP are important in the process of myelination of nerves in the CNS 
(Lazzarini 2004). Increasing evidences indicates that disturbance of myelination is 
found to be associated with progression of many neurological diseases (Philips et al., 
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2013). However, the consequences of the deletion of NF on myelination is unclear. 
Therefore, this thesis has investigated the changes to myelin proteins such as MBP 
and PLP in the CNS of aging NF-L KO mice by using quantitative Western blot. In 
addition, immunofluorescence has been used to study the localization of MBP and 
PLP protein in the brains of aged NF-L KO mice. 
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Chapter 2: Materials and methods  
 
These are the general techniques used across chapters, with specific details in 
individual experimental chapters. 
 
2.1 Animals 
All experiments were approved by the University of Tasmania Animal Ethics 
Committee, which was in accordance with the Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes. The mouse model used in this 
study was a NF-L KO mouse (Zhu et al., 1997), which was a kind gift from Dr Jean-
Pierre Julien (Laval University, Canada) via the colony maintained at the Nathan 
Kline Institute (New York) by Dr Mala Rao. The mouse was bred on a C57Bl/6 
background, which raised the interesting issue as to why the KO has a white colour 
rather than being black. The C57Bl/6 background of NF-L KO mice has been 
confirmed by genotype. The WT control mice were from a separate C57Bl/6 mouse 
colony and not littermates. Male mice were used at postnatal day 4 (P4), 10 weeks, 
4-5 months and 12 months of age. 
 
2.2  Immunohistochemistry and staining of mouse tissue sections 
2.2.1  Transcardial perfusion and preparation of of tissue sections 
Mice were anaesthetised with sodium pentobarbitone (200mg/kg, IP), and 
transcardially perfused with 4% paraformaldehyde (PFA) in phosphate buffer (PBS; 
0.01 M, pH 7.2). The brains and spinal cords were removed and post-fixed in 4%  
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PFA overnight at 4°C.  
 
Tissues were cryoprotected with 18% sucrose in PBS for 24 hours and 30% sucrose 
in PBS for another 24 hours at 4 °C. 40 µm coronal cryostat sections were serially 
collected in PBS with 0.01% NaN3 at 4 °C. 
 
2.2.2 Antigen retrieval 
Tissue cryosections were loaded in two folded pieces of filter paper, sandwiched 
between two foam pads, which had been soaked in 0.01 M citrate buffer (pH 6.0). 
These layers were then placed in the embedding cassettes. The cassettes with tissue 
sections were heated on high power for six minutes in a pressure cooker (Nordic 
Ware, United States), then for four minutes on medium power. The tissue sections 
were cooled to room temperature in citrate buffer before being transferred back into 
0.01 M PBS. Tissue sections were then removed from the tissue cassettes and 
washed three times with 0.01 M PBS for 10 minutes each at room temperature on an 
orbital shaker. 
 
2.2.3 Immunofluorescence  
40 µm brain or spinal cords cryostat sections were washed with 0.01 M PBS before 
non-specific binding sites were blocked in Serum-Free Protein Block solution (Dako, 
Denmark) for 20 minutes at room temperature. Primary antibodies, which recognize 
and bind to specific epitopes of proteins, were applied to the sections at appropriate 
concentrations (Table 2.1),  diluted in a diluent solution (0.3% Triton-X in 0.01 M 
PBS), which is used to permeabilise cell membranes. Optimum concentrations were 
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individually determined for each antibody and control experiments, omitting primary 
antibodies, eliminated all immunoreactivity. Tissue sections were incubated in 
primary antibodies on an orbital shaker for overnight at room temperature or 4°C, 
followed by three 0.01M PBS washes. Species and isotype specific AlexaFluor 
fluorescent secondary antibodies (Molecular Probes, United States; Table 2.2) were 
applied at appropriate concentrations and incubated in the dark, on an orbital shaker 
for 2 hours at room temperature. Sections were washed three times with 0.01 M PBS, 
and mounted onto microscope slides and coverslipped with fluorescence mounting 
medium (Dako, Denmark).  
 
Chapter 2 – Materials & Methods 
 
61 
" 
Table 2.1 Primary Antibodies 
 
Antibody Immunogen Source/supplier 
details 
Working dilution Characteriz
ation 
WB  IF  
INT Purified 
recombinant rat 
alpha-internexin 
 
Novus Biologicals 
Rabbit polyclonal 
NB300-139  
1:5000 1:1000 Blizzard et 
al., 2009 
NFM Highly purified 
primate 
neurofilament 
proteins 
 
AbD Serotec   
Rabbit polyclonal 
AHP246  
1:5000 1:1000 Jones et al., 
2008    
SMI32 Homogenised 
hypothalami of 
rat  
dephosphorylated  
neurofilaments 
 
Sternberger    
Mouse monoclonal 
SMI-32R 
1:1000 1:1000 Sternberger 
and 
Sternberge,
1983 
 
SMI312 Homogenised 
hypothalami of 
rat 
phosphorylated  
neurofilaments 
 
Sternberger    
Mouse monoclonal 
SMI-312R  
1:1000 1:1000 Woodhouse 
et al., 2009 
CR Purified 
recombinant 
human calretinin 
 
Swant 
Rabbit polyclonal 
18299 
1:1000 1:1000 Schwaller 
et al., 1994 
MAP2A 
and 2B 
Bovine brain 
microtubule 
protein 
 
Chemicon  
Mouse monoclonal 
MAB3418 
1:1000 1:1000 Matsunaga 
et al., 1999 
actin N-terminal actin 
peptide (amino 
acid residues 20-
33)    
 
Sigma 
Rabbit polyclonal 
A5060 
1:1000 1:1000 Haase et al., 
2009 
TDP-43 Purified TAR 
DNA binding 
protein    
 
Proteintech 
Rabbit polyclonal 
10782-2-AP 
1:1000 1:500 Huang et al., 
2010 
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pTDP-43 Purified 
phosphoserine 
403/404 TAR 
DNA binding 
protein 
 
Cosmo Bio  Co 
Rabbit polyclonal 
TIP-PTD-P05 
1:1000 1:300 Hasegawa 
et al., 
2008 
MBP Synthetic peptide  
corresponding to 
residues 102-116 
of human Myelin 
Basic Protein 
 
Sigma 
Rabbit polyclonal 
M3821 
  
1:1000 1:200 Encinas and 
Enikolopov, 
2008 
PLP Synthetic peptide 
corresponding to 
C terminal amino 
acids 269-276 of 
mouse myelin 
PLP 
 
Abcam   
Rabbit polyclonal 
ab28488 
 
1:1000 1:1000 Karim et al., 
2007 
CNPase Human purified 
full length native 
CNPase protein 
  
Abcam 
Mouse monoclonal 
ab 6319-100 
1:1000 1:1000 Wu et al., 
2012 
GAPDH Purified GAPDH 
from skeletal 
muscle 
Millipore  
Mouse monoclonal 
MAB374 
 
1:10000   Evdokim
ovskaya 
et al., 
2012 
WB: Western blot; IF: Immunofluorecence 
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Table 2.2  Second antibodies 
 
Antibody Source 
 
 
Working dilution 
WB   IF 
 
Goat Anti-Mouse IgG, 
Horseradish Peroxidase-
Conjugated 
 
Dako   
Goat polyclonal   
P0447 
 
 
1:5000 
 
Goat Anti-rabbit IgG, 
Horseradish Peroxidase-
Conjugated 
Dako 
Goat polyclonal 
P0448   
 
1:5000  
 
 
Alexa Fluor 488 goat anti-
mouse IgG (H+L)  
Molecular Probes 
Goat polyclonal  
A11029 
 
 
 
 
 
1:1000 
Alexa Fluor 546 goat anti-
mouse IgG (H+L)  
Molecular Probes 
Goat polyclonal  
A11030 
 
 
 
 
 
1:1000 
Alexa Fluor 488 goat anti-rabbit 
IgG (H+L)  
Molecular Probes 
Goat polyclonal  
A11034 
 
 
 
 
 
1:1000 
Alexa Fluor 546 goat anti-rabbit 
IgG (H+L)  
Molecular Probes 
Goat polyclonal  
A11035 
 
 
 
 
 
1:1000 
Biotinylated goat anti- mouse 
IgG (H+L)  
VECTOR 
Goat polyclonal  
P1126 
 
 
 
 
 
1:1000 
Biotinylated goat anti-rabbit 
IgG (H+L) 
 
VECTOR 
Goat polyclonal 
K0325 
  
 
 
 
 
 
1:1000 
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2.2.4  4', 6-diamidino-2-phenylindole (DAPI) staining 
 
Tissue sections were incubated in the dark with 0.3mM DAPI (Molecular Probes, 
Invitrogen, United States) in 0.01 M PBS for 20 minutes, at room temperature on an 
orbital shaker. Then, tissue sections were washed three times with 0.01M PBS for 10 
minutes each, at room temperature in the dark on an orbital shaker.   
 
2.2.5  3, 3'-Diaminobenzidine (DAB)- avidin-biotin complex (ABC) staining  
Tissue sections were washed two times with 0.01M PBS for 10 minutes each, at 
room temperature on an orbital shaker. Then, tissue sections were incubated in 3% 
H2O2 in methanol for 20 minutes at room temperature. After three 0.01M PBS 
washes, sections were incubated in Serum-Free Protein Block solution (Dako, 
Denmark) for 30 minutes. Then, blocking solution was removed and sections were 
incubated in primary antibodies at appropriate concentrations (Table 2.1)  or control 
overnight at room temperature, followed by four 0.01M PBS washes. Rabbit or 
mouse sera were used as control. Sections were incubated in species and isotype 
specific biotinylated second antibodies at appropriate concentrations (VECTOR 
Laboratories, United States; Table 2.2) on an orbital shaker for 2 hours at room 
temperature, followed by four 0.01M PBS washes. The Vectastain ABC Kit 
(VECTOR Laboratories, United States) was used for biotin amplification, according 
to manufacturer’s instructions. After three 0.01M PBS washes, the DAB substrate kit 
for peroxidase (VECTOR Laboratories, United States) was used for DAB staining, 
according to manufacturer’s instructions. DAB staining was applied for 2-10 minutes 
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until adequate staining intensity was obtained. After washing in water for 5 minutes, 
sections were post-stained with haematoxylin to label nuclei for 3 minutes. Sections 
were then incubated in ammoniated water for 3 minutes, followed by a water wash. 
After 30 minutes in xylene at room temperature, the tissue sections were 
coverslipped with DPX (Di-N-Butyle Phthalate in Xylene) mounting media (Sigma-
Aldrich, United States). 
 
2.3 Western blot analysis 
2.3.1 Tissue preparation 
WT and NF-L KO mice (n=3 or 5/group) were anaesthetized with sodium 
pentobarbitone (140 mg/kg sodium pentobarbitone, i.p. Virbac, Australia) and 
decapitated. The tissues were dissected and frozen in liquid nitrogen followed by 
storage at -80 °C. 
 
2.3.2 Protein sample preparation 
Proteins from the tissues of NF-L KO mice and WT controls were extracted as 
described previously (Klugmann et al., 1997). The protein concentration of samples 
was determined with Bio-Rad DC protein assay (Bio-Rad Laboratories, United 
States) using bovine serum albumin (BSA) as a standard. Samples were processed in 
triplicate.  
 
2.3.3 Western blot 
Western blots were performed as described previously (Liu et al., 2004b; Staal et al., 
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2011) with modifications. Samples were separated by SDS-PAGE (15µg 
protein/lane; Precise 4-20% or 10% SDS Tris-Glycine gels, Thermo Fisher 
Scientific, United States) according to Laemmli (1970), by using the XCell 
SureLock™ Mini-Cell gel electrophoresis system (Invitrogen, United States). Broad 
range pre-stained molecular protein standards (PageRuler™ Plus; Thermo Fisher 
Scientific, United States) were also run on each gel to allow protein size 
determination. Protein gels were transferred to a polyvinylidene fluoride (PVDF) 
membrane (Bio-Rad Laboratories, United States), and membranes were blocked for 
2 hours in 5% commercial skim milk powder dissolved in Tris-buffered saline with 
0.1% Tween-20 (TBST) at room temperature on an orbital shaker. Blocked 
membranes were incubated overnight at 4°C in primary antibodies diluted in TBST 
(Table 2.1). Membranes were then washed three times in TBST at room temperature 
on an orbital shaker. Species-appropriate goat anti-mouse or anti-rabbit IgG coupled 
to horseradish peroxidase secondary antibodies (Dako, Denmark; Table 2.2) were 
applied and visualized with a chemiluminescent peroxidase substrate kit (Millipore, 
United States). Images were acquired with a Chemi-Smart 5000 Imaging System 
(Vilber Lourmat, Australia) equipped with Chemi-Capt 5000 software. Band 
intensity was measured as the sum optical density by using ImageJ software 
(version1.43u; NIH) and normalized to glyceraldehyde 3-phosphate dehydrogenase 
(GADPH). 
 
2.4 Microscopy 
Confocal images of fluorescence-labelled slides were acquired on a Zeiss LSM 510 
META confocal microscope (Carl Zeiss, Germany) with Zeiss 10X (N.A. 1.0), Zeiss 
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20X (N.A. 1.0) and 63X (N.A. 1.0) objectives. Observation of sections labeled with 
Alexa Fluor 488 secondary antibody was achieved by laser excitation at a 488-nm 
line from an argon laser with emission detected through a 522/35-nm bandpass filter. 
Visualization of sections labeled with Alexa Fluor 546 secondary antibody was 
achieved by laser excitation at a 546-nm line from a helium neon laser with 
emissions detected through a 580/32-nm bandpass filter. The two fluorescence 
images were acquired individually by using the ZE2008 software (Carl Zeiss, 
Germany). Images were acquired using the same acquisition parameters for all 
samples and saved as 8-bit TIFF files for analysis with ImageJ software 
(version1.43u; NIH). For analyses, images were acquired at identical exposure 
settings and adjusted in an identical manner. Images for figures were prepared using 
Adobe Photoshop (CS5).  
 
2.5  Motor function analysis 
Motor function is mediated by several structures, starting in the CTX, brain stem and 
spinal cord, and terminating in skeletal muscle. To assess the locomotion function of 
transgenic mice, this thesis performed gait analysis, which was based on the analysis 
of foot prints-a very good indicator of walking stability and body balance. 
 
Footprint test was performed as described previously (Carter et al., 1999) with 
modifications. Nontoxic BodyArt body/face paint (Global Colours, Australia), 
diluted to a thin consistency with water, was placed on the front (red) and hind (blue) 
paws of a restrained mouse. The mouse then walked along a 7 x 60cm strip of white 
paper bounded on each side by 10cm-high plastic barriers, leaving a trail of paw 
Chapter 2 – Materials & Methods 
 
68 
" 
prints from which various measures could be recorded. The mouse’s feet were rinsed 
in water and dried in a tissue-lined cage; the mouse was then returned to its home 
cage. If the initial walk did not yield a clear set of prints, the procedure was repeated 
once more, and the most consistent pattern from the two attempts was used for 
measurement. Footprint performances were evaluated as described above with three 
trials per day on three consecutive days. 
 
Parameters measured from the stride pattern test were stride length (distance between 
consecutive rear paw prints on the same side), hind-base width (distance between 
right and left hind paws), front-base width (distance between right and left front 
paws) and uniformity measurement (difference in placement of the hind paw 
compared with that of the front paw from the previous step) (Figure 2.1). From each 
stride pattern test strip, stride length and uniformity were measured for 3-5 
consistently-spaced steps on the right and the left sides, and hind-base width and 
front-base width were measured for 3-5 consistently-spaced steps.  
 
2.6 Statistical analysis  
For all experiments, a minimum of three mice were utilized for quantitative analysis. 
Graphs were prepared in Microsoft Excel (Office 2011) or Prism (version 5.0b). 
Error bars represent standard errors of the mean (SEM). Significance was determined 
by ANOVA or t-test, and p<0.05 was considered as significant.   
  
 
 
 
 
 
 
 
 
 
Figure 2.1  Parameters measured from footprints were stride length, hind-base 
width, front-base width and uniformity (adapted from Carter et al., 1999). 
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Chapter 3: Cytoskeletal changes during development and 
ageing in the CTX of NF-L KO mice 
3.1 Introduction 
As noted in Chapter 1, NFs play an important role in the structural integrity of 
neurons and in neuronal development. The mammalian NF triplet is composed of 
three subunit proteins: NF-H (180 to 200 kDa),  NF-M (130 to 170 kDa) and  NF-L 
(60 to 70 kDa) (Fliegner and Liem, 1991; Lee et al., 1996). These triplet subunits are 
co-expressed in a subset of neurons throughout the brain, including a subgroup of 
neocortical pyramidal cells in many species (Vickers and Costa, 1992; Sampson et 
al., 1997; Kirkcaldie et al., 2002; Paulussen et al., 2011). The NF triplet is also 
present in a subset of non-pyramidal and multipolar cortical neurons in humans 
(Sampson et al., 1997) and mice (Van der Gucht et al., 2007; Paulussen et al., 2011).  
 
NF-L is the first NF triplet protein expressed during development (Benson et al., 
1996), and has been purported to play a critical role in the formation of NFs by 
acting as the backbone on which NF-M and NF-H co-polymerise to form IFs (Carter 
et al., 1997).   
 
Previous studies in the spinal cord have shown that genetic deletion of NF-L protein 
resulted in inhibition of dendritic growth, most dramatically in large motor neurons, 
mildly in medium neurons, but with no effect on small neurons (Zhang et al., 2002). 
From as early as 6 months of age, NF-L KO mice are characterized by mild 
sensorimotor dysfunction and spatial memory deficits, but without overt signs of 
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paresis (Dubois et al., 2005). In addition, formation of protein aggregates in motor 
neurons in the spinal cord has been reported in NF-L KO mice from 1 to 6 months of 
age (Li et al., 2006). Moreover, NF-L KO mice have been shown to mimic the 
reduced NF-L mRNA levels seen in ALS resulting in perikaryal accumulation of NF 
proteins and axonal hypotrophy in motoneurons (Wong et al., 2000). Recently, the 
first human case of a homozygous recessive mutation in NF-L has been shown to 
result in a severe, early-onset peripheral neuropathy with reduced numbers of 
myelinated fibers (Yum et al., 2009). 
 
The absence of NF-L protein has been reported to result in significant reduction in 
levels of NF-M and NF-H proteins and increases in the levels of alpha-tubulin and 
GAP-43 in the CTX and sciatic nerve of adult NF-L KO mice (Zhu et al., 1997). In 
this thesis,  relative levels and localization of cytoskeletal proteins were determined, 
especially NF proteins and their modified forms, in the CTX of NF-L KO mice 
relative to WT mice (C57Bl/6) through early postnatal development (P4), in mature 
animals (5 months), as well as aged mice (12 months). The effect of NF-L deletion 
on both cortical pyramidal and non-pyramidal cells, were investigated, the latter 
including a subset of cortical interneurons that are labeled for CR but lack NFTPs.  
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3.2 Materials and methods   
3.2.1 Animals  
NF-L KO mice were maintained on a C57Bl/6 background (Zhu et al., 1997). For the 
purposes of this study, NF-L KO mice were compared to WT mice (C57Bl/6). The 
control mice were from a separate C57Bl/6 mouse colony and not littermates. Male 
mice were used at  P4, 5 months and 12 months of age, selected to be representative 
of young (early postnatal development), mature and aged animals. All experiments 
were approved by the University of Tasmania Animal Ethics Committee.  
 
3.2.2  Tissue preparation  
For Western blot studies, WT and NF-L KO mice at P4, 5 months and 12 months of 
age (n=5/group) were anaesthetized  and decapitated as described in Section 2.3.1. 
Both hemispheres of the neocortex above the rhinal fissure were dissected and frozen 
in liquid nitrogen followed by storage at -80 °C.  
 
For immunofluorescence studies, WT and NF-L KO mice at 5 months of age 
(n=5/group) were anaesthetized and transcardially perfused with 0.01M pH 7.4 PBS, 
followed by 4% PFA as described in Section 2.2.1. Brains were dissected and 
processed for 40 µm coronal cryostat sections of mouse brain, as described in 
Section 2.2.1. 
 
3.2.3 Antibody characterization 
The detailed information for antibodies used in this study is listed in Table 2.1.  
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3.2.4 Western blot  
 
Proteins from the CTX of P4, 5 month-old and 12 month-old NF-L KO mice and WT 
controls (n=5 /group) were extracted as described previously (Klugmann et al., 
1997). Protein concentration was determined with Protein Assay (Bio-Rad 
Laboratories, United States) using BSA as a standard. Proteins (15 µg) were 
separated by 4-20% or 10% SDS-PAGE and blotted onto a PVDF membrane (Bio-
Rad Laboratories, United States) as described in Section 2.3.3. Primary antibody 
(Table 2.1) binding was visualized by goat anti-mouse or anti-rabbit IgG coupled to 
horseradish peroxidase (Dako, Denmark; Table 2.2). Immunoreactive bands were 
visualized and measured as described in Section 2.3.3.   
 
3.2.5  Immunofluorescence  
Free-floating 40µm brain cryostat sections were incubated overnight at 4°C with 
primary antibodies (Table 2.1) in diluent (0.3% Triton X-100, 0.01M PBS) as 
described in Section 2.2.3. Sections were then washed with 0.01M PBS and 
incubated with Alexa Fluor 546 conjugated to goat anti-mouse, or Alexa Fluor 488 
conjugated to goat anti-rabbit IgG (Molecular Probes, United States) (Table 2.2) as 
described in Section 2.2.3. Sections were washed with PBS before mounting onto 
Fisher Super Frost Plus slides using fluorescent mounting medium (Dako, Denmark), 
and air-dried in the dark. 
 
Chapter 3 – Results  
 
73 
" 
3.2.6 Image acquisition 
Fluorescence-labeled sections were viewed with a Zeiss LSM 510 META confocal 
microscope (Carl Zeiss, Germany) and images acquired using ZEN software (Carl 
Zeiss, Germany) as described in Section 2.4. Digital images were compiled in Adobe 
Photoshop CS4 (Adobe, United States). 
 
3.2.7 Analysis of effect of NFL deletion on non-pyramidal neurons 
For analyses of calretinin immunolabelled interneurons and their laminar 
distribution, sections of different cortical regions (motor and sensory CTX) labeled 
in the same experiment, were viewed with an upright Leica fluorescent microscope 
(Leica Microsystems GmbH, Germany) and an Olympus digital camera (Olympus 
Corporation, Japan). Images were imported into Adobe Photoshop CS4 (Adobe, 
United States) and analyzed with ImageJ. Cortical layers were delineated based on 
labeling with red FluoroNissl (Molecular Probes, United States). Interneurons, 
immunolabelled for CR, were counted across all the layers of the motor (M1, M2) 
and sensory CTX (S1BF, 4 images/region/mouse, 5 NF-L KO and 3 WT mice, 5 
months of age). 
 
3.2.8 Statistical Analysis 
For all experiments, a minimum of three mice was utilized for quantitative analysis. 
Error bars represent SEM. Significance was determined by two-way ANOVA, with 
Bonferroni corrections made for multiple comparisons within a single experiment.   
p<0.05 was considered significant. 
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3.3 Results  
3.3.1 Changes to expression of intermediate filament protein expression during 
development 
Western blot analysis of the expression of IFs in WT and NF-L KO mice showed 
that protein levels differed significantly between genotypes. In this experiment, each 
protein was analyzed using a separate 2-way ANOVA with genotype and age as 
factors.   
 
• SMI 32 
This antibody labels dephosphorylated epitopes of medium and heavy NF triplet, and 
is expressed in perikarya, dendrites, and developing axons. In CTX, WT animals 
showed low levels at P4, a peak at 5m and low levels at 12m; KO mice showed very 
low levels at all ages, significantly less than WT at P4 and 5m (Figure 3.1 A). 
 
• SMI 312 
 
This monoclonal antibody labels phosphorylated epitopes of medium and heavy NF 
triplet, and is expressed in mature axons. In WT CTX, SMI 312 labeling was 
complementary to SMI 32: high levels at P4, low levels at 5m and high at 12m. KO 
mice levels were lower at all ages: moderate levels were present at P4 and then 
virtually absent at 5m and 12m. The WT-KO difference was significant at P4 and 
12m, but not at 5m (Figure 3.1 B). 
 
  
 
 
 
Figure 3.1  Changes of cytoskeletal protein expression in the CTX of NF-L KO mice 
and their WT controls at P4, 5 months and 12 months of age (n=3). Equal amounts of 
brain tissue were separated on a gel and labeled with the following antibodies: SMI 
32(A), SMI 312 (B), NFM (C) and INT (D). The changes of target proteins in NF-L 
KO mice are expressed as percentages relative to WT controls (*p<0.001). GAPDH 
served as a loading control.  
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• NFM 
This antibody labels the medium weight NF triplet regardless of phosphorylation. In 
the CTX of WT mice, levels were similar at P4, 5m and 12m, whereas in the KO 
mice levels were significantly less at P4 and 5m, but similar at 12m (Figure 3.1 C). 
 
• INT 
This antibody labels INT, a class IV neuronal intermediate filament, which has the 
capacity to form IFs as a homo-polymer but can also co-polymerise with NF triplet 
protein (Cui et al., 1995). In WT animals, INT levels declined steadily from P4 to 
12m, whereas in KO mice, INT levels were significantly less at P4 and 5m, then 
significantly greater at 12m (Figure 3.1 D). 
 
3.3.2 Alterations in localization of neurofilament proteins in cortical neurons of 
NF-L KO mice  
To determine whether significant changes in total amounts of each cytoskeletal 
component could translate into altered processing, transport and distribution within 
the cell, confocal analysis of INT, NFM, phosphorylated and dephosphorylated NF 
(NF-P and NF-DP) immunolabeling in the sensory CTX (S1BF) of WT and NF-L 
KO mice at 5 months of age was undertaken. The somatosensory CTX at 5 months 
was selected for this study as it has been reported that, from as early as 6 months of 
age, NF-L KO mice were characterized by mild sensorimotor dysfunction (Dubois et 
al., 2005). 
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SMI 312 immunolabeling of nerve fibers was present in axons of cortical neurons in 
WT control mice (Figure 3.2 A), but substantially reduced in layer 2/3 of the CTX of 
NF-L KO mice (Figure 3.2 B). SMI 312 labeling was absent from cell bodies and 
dendrites in WT mice (Figure 3.2 A). In contrast, SMI 312 immunolabeling was 
occasionally localized to perikarya of cortical pyramidal neurons in layer 2/3 of the 
CTX of NF-L KO mice (Figure 3.2 B).There were, likewise, relatively fewer NF-M 
labeled neurites in layer 2/3 of the CTX of NF-L KO mice (Figure 3.3 B, D) relative 
to WT animals (Figure 3.3 A, C). INT-immunoreactive nerve fibers were present in 
the layer 2/3 of CTX of WT controls (Figure 3.4 A) and that of NF-L KO mice 
(Figure 3.4 B). The density of INT labeled fibers was lower in the NF-L KO mice as 
compared to WT control mice (Figure 3.4 A, B). SMI 32 immunolabeling was 
localized to cell bodies, dendrites and some thick axons in WT mice (Figure 3.5 A). 
However, SMI 32 immunolabeling demonstrated abnormal accumulation in the cell 
bodies of pyramidal neurons in layer 2/3 (data not shown) and layer 5 of the CTX of 
NF-L KO mice (Figure 3.5 B).  
 
3.3.3 Changes to expression of other cytoskeletal proteins in the CTX of NF-L 
KO mice 
Expression of other cytoskeletal proteins, such as MAP2, neuron-specific class III 
beta-tubulin and beta-actin, were investigated in the CTX of NF-L KO relative to 
WT mice by Western blot analysis (Figure 3.6 A). The expression level of MAP2 
(Figure 3.6 B) and type III beta-tubulin protein (Figure 3.6 C) was significantly 
(P<0.05) increased in the CTX of NF-L KO mice at P4, 5 months and 12 months of 
age, as compared with WT animals. In addition, the levels of beta-actin protein 
  
 
 
 
 
Figure 3.2 Immunofluorescence labeling for phosphorylated NFs (SMI 312) in layer 
2-4 of the CTX of WT (A) and NF-L KO (B) mice at 5 months of age. Arrows 
indicate examples of cell bodies of pyramidal neurons. Scale bar, 50 µm. 

  
 
 
 
Figure 3.3 NFM immunolabeling in layer 2-4 (A, B) and layer 2/3 (C, D) in the 
CTX of WT (A, C) and NF-L KO (B, D) mice at 5 months of age. Arrows indicate 
examples of cell bodies of pyramidal neurons. Scale bars, A, B 50µm; C, D 20 µm. 

  
 
 
 
Figure 3.4 Confocal microscope images of INT labeling in layer 2-4 of the CTX 
from NF-L KO (B) and WT control mice (A) at 5 months of age. Scale bar, 50 µm.  

  
 
 
 
Figure 3.5 Confocal microscope images of layer 5 of the CTX immunolabeled for 
SMI 32 in WT (A) and NF-L KO (B) mice at 5 months of age. Arrows point to 
examples of cell bodies of pyramidal neurons. Scale bar, 20 µm. 

  
 
 
Figure 3.6  Changes in MAP2, class III beta-tubulin and beta-actin expression in the 
cortex of NF-L KO mice compared to WT mice at P4, 5 months and 12 months of 
age (n=3). A: Western blot analysis of MAP2, class III beta-tubulin and beta-actin. 
B-D: Relative amount of the protein expression of MAP2 (B), class III beta-tubulin 
(C) and beta-actin (D) normalized with GAPDH respectively (*p<0.001). GAPDH 
served as a loading control. 
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(Figure 3.6 D) were significantly (P<0.05) increased in the CTX of NF-L KO mice at 
P4.  
 
3.3.4 Analysis of the effect of NF-L deletion on non-pyramidal neurons 
To investigate the effect of NF-L deletion on non-pyramidal cells, CR labeling was 
used to identify a subset of inhibitory neurons (interneurons) that do not contain 
NFTPs. The distribution of CR labeled neurons was also used to assess broad 
cytoarchitectural changes with respect to cell location between WT and NF-L KO 
mice. 
 
First, the expression of CR in the CTX of NF-L KO mice was analyzed by Western 
blotting (Figure 3.7 A, B). Compared with WT controls, CR protein levels in NF-L 
KO mice were significantly reduced at both P4 and 12 months of age (p<0.01 and 
P<0.001, respectively; Figure 3.7 B).  
 
The distribution of CR-positive neurons across cortical layers at 5 months was 
investigated to assess whether the distribution of non-NF triplet-containing neurons 
was altered by the cytoskeletal changes observed. S1BF and M1/M2 were chosen for 
analysis because they are adjacent to each other in the CTX, but differ noticeably in 
their NF triplet-labeling pattern (Paulussen et al., 2011), suggesting that any 
architectonic effects of NF-L deletion would differ between them. Counts of CR-
positive neurons in each cortical layer for S1BF (sensory CTX) and M1/M2 (motor 
CTX) were analyzed using two-way ANOVA. For both regions, the counts of CR-
positive neurons differed significantly between cortical layers (p < 0.0001; Figure 
  
 
 
Figure 3.7: Analysis of effect of NF-L deletion on non-pyramidal neurons. A: 
Western blot analysis of calretinin protein in the cortex from NF-L KO mice and 
their WT controls at P4, 5 months and 12 months of age (n=3). GAPDH served as a 
loading control. B: Relative changes in CR protein in NF-L KO mice compared with 
WT controls (*p<0.01). C, D: Distribution of interneuron population with CR marker 
in adult motor (C) and sensory cortex (D) of NF-L KO mice and their WT controls at 
5 months of age. Y-axis represents mean numbers of cortical neurons labeled with 
the CR per mm2. E, F: CR immunolabeling in layer 2/3 of the cortex in WT (E) and 
NF-L KO (F) mice at 5 months of age. Scale bar, 50 µm. 
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3.7 C, D), but there was no overall effect of genotype, and no interaction between 
genotype and layer (meaning that the same laminar distribution was observed for all 
layers of the WT and KO mice). The "hump" in the M1/M2 graph (Figure 3.7 C) 
reflects the absence of layer 4 in this area, resulting in increased numbers of CR-
positive neurons in the enlarged layer 5. In summary, there were no significant 
differences in the laminar distribution of CR neurons in either region or the total 
number of labeled cells in the NF-L KO mice compared to the WT animals.  
 
In addition, confocal images of CR labeled neurons in layer 2/3 of adult CTX at 5 
months showed no observable change of CR labeling distribution within the different 
compartments of the labeled neurons (Figure 3.7 E, F).  !

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3.4 Discussion   
Deletion of NF-L protein in mice significantly altered the expression of other 
neuronal intermediate filament proteins in the CTX at various ages, as assayed by 
Western blotting. The differing profiles of NF subunits and phosphorylation states 
(Fig 3.1A-D) presumably reflect altered NF assembly and phosphorylation, 
beginning at P4 when all of the markers of IFs are significantly reduced in KO 
animals. WT animals showed a great increase in NF-P labeling between 5 and 12 
months, with a corresponding reduction in NF-DP labeling suggesting that 
widespread phosphorylation is taking place, masking the NF-DP epitope. NF-L KO 
mice were low in expression for both NF-DP and NF-P at these ages, indicating a 
lack of the normal NF forms, which these antibodies detect. In WT animals, INT 
labeling was initially high but decreased steadily as the CNS matured, whereas NF-L 
KO resulted in reduced INT expression at P4 and 5 months, but with a marked 
increase from 5 to 12 months. This may reflect a partially successful compensatory 
response in which INT substituted for NF-L to assemble NFs. If this was the case, 
the resultant filaments were not detected by SMI 32 or SMI 312, presumably due to a 
lack of recognizable epitopes. This scenario is consistent with the data from this 
thesis on the expression of NF-M, consistent at all ages in WT animals, but initially 
lower in the NF-L KO mice, then increasing at the time INT demonstrated increased 
expression. Although previous studies have found that, in the absence of NF-L, NF-
M and NF-H subunits are not able to assemble into 10 nm filaments alone (Carter et 
al., 1997), the data present in this thesis suggest that INT could potentially 
compensate for an absent in NF-L because of its type IV neuronal IF similarities 
(Yuan et al., 2006b). 
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These changes of NF-DP proteins detected by Western blotting were also associated 
with changes found by immunohistochemistry in the typical cellular localization of 
NF-DP proteins in cortical neurons of 5-month-old NF-L KO mice.  Moreover, the 
deletion of NF-L resulted in reduced CR protein expression without affecting the 
distribution of cortical interneurons labeled for this protein. In addition, increased 
expression of MAP2 and neuron-specific class III beta-tubulin were found at P4, 5 
months and 12 months of age. These findings suggest that the deletion of NF-L may 
be compensated for by alterations in other cytoskeletal proteins without necessarily 
disrupting cortical structure or connectivity. 
 
Mice lacking NF-L exhibit a scarcity, but not a complete absence, of neuronal IF 
structures associated with a reduction in adult cortical levels of NF-M and NF-H 
(Zhu et al., 1997). Combined with the current findings, this suggests that NF-L is a 
critical backbone protein to which NF-M and NF-H co-polymerize to form NFs 
(Carter et al., 1997), which can only partially be compensated for by increased INT 
expression.  
 
In WT rodent brains, NF proteins and INT are enriched in a subset of cortical 
pyramidal cells (Kirkcaldie et al., 2002; Dickson et al., 2005; King et al., 2006; 
Paulussen et al., 2011). Although it has been demonstrated that NF-L KO disrupts 
filament expression and localization, there is little apparent effect on overall cortical 
structure. The observed abnormalities in, for example, NF-DP labeling of soma, are 
probably due to defective NF assembly as well as the transport of these proteins into 
axons. When NF-L expression is disrupted in Japanese quail, axonal transport of NF 
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proteins is impaired, with subsequent accumulation of NF-H and NF-M in the cell 
body of motor neurons, similar to that seen in ALS (Toyoshima et al., 2000).  
 
The compensatory increases in expression of other cytoskeletal components may 
explain why the NF-L KO mouse does not exhibit a major neurological/behavioral 
phenotype. NF-L KO mice have mild sensorimotor dysfunction and spatial memory 
deficits, but no severe symptoms such as overt signs of paresis (Dubois et al., 2005). 
This may indicate a lack of functional disruption, or that the neocortex is relatively 
unimportant in mouse behavior (Kirkcaldie, 2012). The adaptive changes in other 
cytoskeletal proteins underlines the inter-relationship of NFs, MTs and MFs in 
maintaining neuronal structure and function (reviewed in Julien et al., 2000).  
 
To assess whether these changes affected other cells, interneurons labeled for CR 
were examined, that typically lack the NFTPs (Sampson et al., 1997; Blizzard et al., 
2011). CR is a calcium-binding protein, which helps to buffer calcium within 
neurons (Sampson et al., 1997) and may modulate excitability in the neurons which 
express it (Camp and Wijesinghe, 2009). There was no difference in total cell 
number or laminar distribution of CR positive neurons in the NF-L KO CTX in 
either the motor (M1, M2) or sensory (S1BF) regions in the adult CTX (Fig. 3.7E, 
F), in accordance with the existing literature (Conde et al., 1994; DeFelipe et al., 
1999; Park et al., 2000; Yamashita et al., 2003). However, the amount of cortical CR 
protein was reduced in the NF-L KO mice, which may imply functional changes in 
these interneurons, which typically synapse onto pyramidal neurons affected by the 
reduced NF levels (Kirkcaldie, 2012). 
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In conclusion, these findings indicate that there are compensatory changes in 
expression and distribution of cytoskeletal components in central nervous system 
neurons which lack NF-L, and that the lack of NF proteins does not affect the 
structure and cytoarchitecture of the adult CTX. These results indicate a close and 
dynamic inter-relationship between cytoskeletal proteins in the maintenance of the 
structure and function of the neuronal cytoskeleton, and a resilience of cortical 
structure to changes imposed by cytoskeletal disruption. 
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Chapter 4: Changes to TDP-43 expression in ageing NF-L 
KO mice 
 
4.1 Introduction 
TDP-43 is a 414 amino-acid hnRNP encoded by the TARDBP gene (Ou et al., 
1995), which was identified as a transcriptional repressor that binds to both DNA and 
RNA with multiple functions such as transcriptional repression, pre-mRNA splicing 
and translational regulation (reviewed in Buratti and Baralle, 2008; Wang et al., 
2008). TDP-43 is also a NF-L mRNA binding protein, acting to stabilize mRNA 
transcription and also with a role in NF mRNA metabolism and transport (Strong et 
al., 2007). 
 
Normally, TDP-43 is localized to the nucleus. However, pathologic TDP-43, 
(cytosolic aggregation, ubiquitination, abnormal phosphorylation and proteolytically 
cleaved C-terminal fragments of TDP-43) becomes localised to the cytoplasm 
(Neumann et al., 2006; Winton et al., 2008). TDP-43 mislocalization is associated 
with a reduction in NF-L mRNA levels (Caccamo et al., 2009). Pathologic TDP-43 is 
a primary component of ubiquitin-positive and alpha-synuclein-negative inclusions 
in affected brain and spinal cord regions of patients with FTLD-TDP and ALS, 
known as TDP-43 proteinopathies (Neumann et al., 2006; Armstrong et al., 2013). In 
addition, TDP-43 pathology has also been detected in PD, dementia with Lewy 
bodies and AD cases (Amador-Ortiz et al., 2007b; Higashi et al., 2007; Bigio, 2008; 
Uryu et al., 2008; Wilson et al., 2011). The reason for the abnormal cytoplasmic 
localization of TDP-43 in these neurodegenerative diseases is unknown. One 
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possible mechanism may relate to dysfunction of cellular apoptosis susceptibility, 
which is deficient in FTLD and ALS patients (Nishimura et al., 2010). A recent 
study has described Rho guanine nucleotide exchange factor as an NF-L mRNA 
destabilizing factor that forms cytoplasmic inclusions in ALS (Droppelmann et al., 
2013). Hence, alterations in RNA metabolism in motor neurons may explain the 
development of protein inclusions, including the neurofilamentous aggregates, 
observed in ALS pathology (Droppelmann et al., 2013). 
 
Pathogenic mutations in the TDP-43 gene have been identified in sporadic and 
familial ALS (Gitcho et al., 2008; Sreedharan et al., 2008; Yokoseki et al., 2008). In 
addition, an A90V mutation has been identified in a FTLD patient with a family 
history of dementia (Winton et al., 2008). Recently, a mutation in the TDP-43 gene 
has been detected in a family presenting with PD, who later develop ALS and FTLD 
(Mosca et al., 2012). Collectively, this suggests a direct link between TDP-43 
abnormalities and neurodegeneration across a range of conditions.  
 
TDP-43 has been reported to be upregulated in the cerebrospinal fluid of patients 
with ALS (Kasai et al., 2009) and in peripheral blood lymphocytes from ALS 
patients (Mougeot et al., 2011; Nardo et al., 2011). Overexpression of the normal 
human TDP-43 gene causes neurodegeneration in transgenic animals such as 
Drosophila, monkey and rat (Li et al., 2010; Uchida et al., 2012).  
 
The finding that TDP-43 regulates NF-L mRNA may provide a potential link to ALS 
in which NF-L mRNA expression is decreased and pathologic TDP-43 is present 
(Caccamo et al., 2009). In addition, NF-L KO mice have been shown to mimic the 
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reduced NF-L mRNA levels seen in ALS resulting in perikaryal accumulation of NF 
proteins and axonal hypotrophy in motoneurons (Wong et al., 2000). However, 
causes and effects are unclear. Hence, this chapter investigated whether alteration in 
NF-L expression affected TDP-43. In order to determine whether deficiency of NF-L 
protein resulted in pathologic TDP-43, the relative levels and localization of TDP-43 
were investigated in the CTX and spinal cord of young (10 weeks) and aged (12 
months) NF-L KO mice, relative to age-matched WT mice (C57Bl/6). This study 
demonstrated that lack of NF-L protein or mRNA expression can affect the 
expression levels of TDP-43 in the CTX and spinal cord, and was associated with 
motor dysfunction, however, this does not result in pathologic accumulations of 
TDP-43. 
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4.2  Methods and materials 
4.2.1 Animals  
As described in Section 2.1, NF-L KO mice were maintained on a C57Bl/6 
background (Zhu et al., 1997). For the purposes of this study, NF-L KO mice were 
compared to WT mice (C57Bl/6). Male mice were used at 10 weeks, 4 months and 
12 months of age. All experiments were approved by the University of Tasmania 
Animal Ethics Committee.  
 
4.2.2 Body weight 
The body weights of four NF-L KO mice and four WT mice at 12 months of age 
were measured.  
 
4.2.3 Footprint  test 
The footprint test (Carter et al., 1999) was used to compare the gaits of NF-L KO 
mice with that of WT control mice. Three NF-L KO mice and 5 WT mice at 4 
months of age, 4 NF-L KO mice and 4 WT mice at 12 months of age were tested as 
described in Section 2.5. Parameters of footprint including the stride length (mm), 
base width (mm) and uniformity (mm) were measured.  
 
4.2.4 Tissue preparation  
For Western blot studies, WT and NF-L KO mice at 10 weeks and 12 months of age 
(n=3/group) were anaesthetized and decapitated as described in Section 2.3.1. Tissue 
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samples of CTX, HIP and corpus callosum (CC) and cervical spinal cord (SC-C), 
thoracic spinal cord (SC-T) and lumbar spinal cord (SC-L) were dissected and frozen 
in liquid nitrogen followed by storage at -80 °C. 
 
For immunohistochemistry and immunofluorescence studies, WT and NF-L KO 
mice at 10 weeks and 12 months of age (n=3/group) were anaesthetized and 
transcardially perfused as described in Section 2.2.1. Sections of brains and lumbar 
spinal cords were prepared as described in Section 2.2.1.  
 
4.2.5 Western blot   
Western blots were performed as described in Section 2.3 with modifications. 
Proteins from the CTX, HIP, CC, SC-C, SC-T and SC-L of 10-week old and 12-
month old NF-L KO mice and WT controls (n=3 each) were extracted as described 
in Section 2.3.2. Protein concentration was determined with Protein Assay (Bio-Rad) 
using BSA as a standard. Proteins (15µg) were separated by 4-20% SDS-PAGE and 
blotted onto a PVDF membrane as described in Section 2.3.3. Primary antibody 
(Table 2.1) binding was visualized by goat anti-mouse or anti-rabbit IgG coupled to 
horseradish peroxidase (Dako, Denmark; Table 2.2). Immunoreactive bands were 
visualized and measured as described in Section 2.3.3.   
 
4.2.6 Immunohistochemistry and Immunofluorescence  
40 µm brain or spinal cord cryostat sections were treated with antigen retrieval as 
described in Section 2.2.2.  Then non-specific binding sites of the sections were 
blocked in Protein Block, Serum-Free (Dako, Denmark) solution for 20 minutes at 
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room temperature. Following blocking, the sections were washed with 0.01 M PBS, 
they were then incubated overnight at 4°C with primary antibodies (Table 2.1) in 2x 
diluent (0.6% Triton X-100 in 0.01 M PBS). For immunoperoxidase labelling, 
primary antibodies were visualised using a DAB staining system (VECTOR 
Laboratories, United States) as described in Section 2.2.5. For immunofluorescence, 
sections were washed with 0.01M PBS and incubated with Alexa Fluor 488 
conjugated to goat anti-mouse or Alexa Fluor 546 conjugated to goat anti-rabbit IgG 
(Molecular Probes, United States; Table 2.2). Sections were washed with PBS before 
mounting onto Fisher Super Frost Plus slides using fluorescent mounting medium 
(Dako, Denmark), and air-dried in the dark. Nuclei were counterstained with DAPI 
as described in Section 2.2.4. !
4.2.7  Image acquisition 
Fluorescence-labeled sections were viewed with a Zeiss LSM 510 META confocal 
microscope (Carl Zeiss, Germany) and images acquired as described in Section 2.4.   
 
4.2.8 Statistical Analysis 
Statistical analysis was undertaken as described in Section 2.6. For footprint analysis, 
a non-parametric t-test was used to determine differences on uniformity parameter. 
One-way ANOVA followed by a Tukey post-hoc was used to determine differences 
in the stride length (mm) and base width (mm) parameters, respectively.    
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4.3 Results 
4.3.1 Reduced body weight in aged NF-L KO mice 
To determine if lack of NF-L resulted in the change of body weight in aging NF-L 
KO mice, the body weight of 4 NF-L KO mice (Figure 4.1 B) and 4 WT mice 
(Figure 4.1 A) at 12 months of age was assessed. The body weight of NF-L KO mice 
at 12 months was 21% lower than that of age-matched WT mice (Figure 4.1 C), 
which was similar to a previous report that young NF-L KO mice (19 to 28 weeks) 
had a lower body weight than WT mice (Dubois et al., 2005). It was interesting that 
NF-L KO mice show white colour rather than being black as normal C57Bl/6 mice. 
However, the reason remained unknown.   
 
4.3.2 Changes to TDP-43 expression in the brain and spinal cord of aged NF-L 
KO mice  
To determine if the expression of TDP-43 was affected by ageing in NF-L KO mice,  
the expression of TDP-43 in the brain and spinal cord of NF-L KO relative to WT 
mice at 12 months was investigated by Western blot analysis. To determine whether 
there were regional alterations in the levels of TDP-43, studies of  three regions of 
brain—CTX, HIP and CC and three regions of spinal cord—SC-C, SC-T and SC-L 
were undertaken. TDP-43 protein was significantly increased (P<0.05) in the CTX of 
NF-L KO mice at 12 months of age, as compared with WT animals (Figure 4.2). 
Furthermore, there was a significant increase (P<0.05) of the level of TDP-43 protein 
in the SC-L of 12-month old NF-L KO mice (Figure 4.3). However, TDP-43 
expression in other regions of the brain and spinal cord of NF-L KO mice was not 
  
 
 
 
Figure 4.1 Body weight of NF-L KO and WT (C57BL/6 ) mice at 12 months of age. 
(A) WT mouse at 12 months of age. (B) NF-L KO mouse at 12 months of age. (C) 
Body weight of NF-L KO mice at 12 months was significantly (P<0.05) lower than 
that of age-matched WT mice. All values are expressed as the mean ± SEM. Asterisk 
indicates p<0.05.   

  
 
 
 
Figure 4.2  Western blot analysis of TDP-43 protein expression in the CTX, HIP and 
CC of NF-L KO mice and WT controls at 12 months of age (n=3/group). Equal 
amounts of brain tissue were separated on a gel and labeled with the TDP-43 
antibody. Relative amounts of  protein expression of TDP-43 were normalized with 
GAPDH (*p<0.05).  

  
 
 
 
Figure 4.3 Western blot of TDP-43 protein in the  SC-C, SC-T, SC-L of NF-L KO 
mice and WT controls at 12 months of age (n=3/group). Equal amounts of tissue 
were separated on a gel and labeled with TDP-43 antibody. Relative amounts of the 
protein expression of TDP-43 were normalized with GAPDH (*p<0.05).  
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significantly different to control animals. 
 
4.3.3 Localization of TDP-43 in the brain and spinal cord of aged NF-L KO 
mice   
As TDP-43 protein was significantly increased in the CTX and SC-L of 12-month 
old NF-L KO mice relative to WT animals, confocal microscopy was used to 
examine the brain and SC-L sections immunolabelled with antibodies to TDP-43. In 
order to investigate if the lack of NF-L resulted in alterations in the localization of 
TDP-43 in neurons, sections were also stained with DAPI. The merged images of 
TDP-43 (red) and DAPI (blue) showed that TDP-43 was increased in cortical 
neurons (Figure 4.4) and neurons in the ventral horn region of the SC-L (Figure 4.5) 
of NF-L KO mice at 12 months of age, compare to WT animals. However, no 
mislocalization of TDP-43 from the nucleus to the cytoplasm was observed. DAB 
staining confirmed that there were increased TDP-43 protein (brown) in the CTX of 
WT and NF-L KO mice at 12 months of age, without TDP-43 mislocalization, 
compared to WT animals (Figure 4.6).  
 
4.3.4 Alterations in TDP-43 expression in the brain and spinal cord in 10-week 
old NF-L KO mice 
To better understand whether the loss of NF-L gene altered TDP-43 expression in the 
brain and spinal cord in earlier life stages of NF-L KO mice, the expression levels of 
TDP-43 were investigated in NF-L KO and WT mice at 10 weeks of age. Western 
blotting showed that the expression levels of TDP-43 were significantly increased  in 
all three regions of spinal cord, including SC-C (p<0.001), SC-T (p<0.0001) and SC-
  
 
 
 
Figure 4.4 Confocal microscope images of TDP-43 labelling (red) in the CTX from 
NF-L KO (D-F) and WT (A-C) control mice at 12 months of age. Nuclei were 
labelled with DAPI (blue). Note increased TDP-43 labelling (arrows) in NF-L KO 
mice. Scale bar, 20 μm. 

  
 
 
Figure 4.5 Confocal microscope images of the SC-L immunolabelled for TDP-43 
(red) in WT (A-C) and NF-L KO mice (D-F) at 12 months of age. Nuclei were 
labelled with DAPI (blue). Note increased TDP-43 labelling (arrows) in NF-L KO 
mice. Scale bar, 20 µm. 

  
 
 
 
Figure 4.6 DAB staining (brown) for TDP-43 in the CTX of WT (A) and NF-L KO 
(B) mice at 12 months of age. Nuclei were post-stained with haematoxylin (blue). 
Scale bar, 30 µm. 
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L (p<0.05) of 10-week-old NF-L KO mice, compared to WT mice (Figure 4.7). 
However, there was no significant change in TDP-43 protein abundance in the CTX, 
HIP and CC between NF-L KO and WT mice at 10 weeks of age (Figure 4.8). 
 
In addition, TDP-43 immunolabelling was also increased in the ventral horn region 
of the spinal cord of  NF-L KO mice relative to WT animals at 10 weeks of age 
(Figure 4.9). 
 
4.3.5  Motor dysfunction in young and aged NF-L KO mice 
Footprint analysis was carried out to determine if the increase of TDP-43 in the 
spinal cord correlated with motor dysfunction in young and aged NF-L KO mice. 
Footprint patterns of WT and NF-L KO mice at 4 months and 12 months of age are 
illustrated in Figure 4.10. WT mice at 12 months of age, walked in a straight line, 
with a regular even alternating gait (Figure 4.10). By contrast, NF-L KO mice had 
staggering movements, and a gait that lacked a uniform pattern (Figure 4.10). 
 
The resulting footprint patterns were assessed quantitatively by four measurements: 
stride length of front and hind paws, base width of front and hind paws and 
uniformity (the distance from front footprint/hind footprint overlap) (Figure 4.10). At 
4 and 12 months, NF-L mice exhibited a significantly (p<0.05) shorter stride length 
of front and hind paws (Figure 4.10), as compared with age-matched controls. In 
addition, at 4 months, NF-L KO mice displayed a significantly (p<0.05) greater 
uniformity compared with control mice (Figure 4.10), and this effect became more 
pronounced as the mice got older (12 months) (Figure 4.10). These data indicate that 
  
 
 
 
 
Figure 4.7  Western blot analysis of TDP-43 protein expression in the  SC-C, SC-T, 
SC-L of NF-L KO mice and WT controls at 10 weeks of age (n=3/group). Equal 
amounts of tissue were separated on a gel and labeled with TDP-43 antibody. 
Relative amounts of the protein expression of TDP-43 were normalized against 
GAPDH (*p<0.05, **p<0.001, ***p<0.0001).  

  
 
 
 
 
Figure 4.8 Western blot analysis of TDP-43 protein expression in the  CTX,  HIP 
and CC of NF-L KO mice and WT controls at 10 weeks of age (n=3/group). Equal 
amounts of tissue were separated on a gel and labeled with TDP-43 antibody. 
Relative amounts of the protein expression of TDP-43 were normalized against 
GAPDH.  

  
 
 
 
Figure 4.9 Immunofluorescence labeling for TDP-43 in the ventral horn region of 
spinal cord of WT (A) and NF-L KO (B) mice at 10 weeks of age.  Scale bars, 50 
µm. 

  
 
 
 
 
Figure 4.10 Footprint analysis of NF-L KO mice and WT controls at 4 and 12 
months, respectively, including stride length, base width and uniformity 
measurement. All values are expressed as the mean ± SEM (* p<0.05). 

Chapter 4 – Results  
 
92 
" 
the NF-L animals show a motor deficit from early ages (4 months) and this motor 
deficit becomes worse with ageing (12 months). 
 
4.3.6 Phosphorylation state of TDP-43 in the spinal cords of 10-week-old and 12-
month-old NF-L KO mice 
Levels of phosphorylated TDP-43, a marker of pathologic TDP-43, were assessed in 
the spinal cords of NF-L KO mice and WT controls by Western blotting. High 
molecular weight  bands were not detected on the normal TDP-43 immunoblotting 
gel suggesting that the phosphorylation is at low levels in normal tissue. In both 
spinal cords of WT and NF-L KO mice, immunoblot of pTDP-43 (pS403/404) 
demonstrated two bands at 25 kDa and 45 kDa, with additional fragments. Labelling 
intensity of 45 KDa band is high at 10 weeks and low at 12 months in WT and NF-L 
KO mice. As determined by densitometric analysis of Western blot, the level of 
pTDP-43 protein was significantly (p<0.05) increased  in the SC-T of 10-week-old 
NF-L KO mice (Figure 4.11), compared to WT controls. Moreover, an increase of 
pTDP-43 was detected in the SC-C of NF-L KO mouse at 12 months (Figure 4.12), 
compared to WT mice. These findings suggest that in the spinal cord of NF-L KO 
mice, there are subtle changes in amounts of pTDP-43, but the banding patterns are 
the same. 
 
4.3.7 Change to pTDP-43 in the brains of NF-L KO mice at 10 weeks and 12 
months of ages  
To determine the phosphorylation state of TDP-43 in the brain of NF-L KO mice, 
Western blotting was used to measure the level of pTDP-43 in brains of 10-week old 
  
 
 
 
 
Figure 4.11 pTDP-43 protein expression in the SC-C, SC-T, SC-L of NF-L KO mice 
and WT controls at 10 weeks of age (n=3/group). Equal amounts of tissue were 
separated on a gel and labeled with the pTDP-43 antibody. Relative amounts of the 
protein expression of pTDP-43 were normalized against GAPDH (*p<0.05).  

  
 
 
 
Figure 4.12 pTDP-43 protein expression in the SC-C, SC-T, SC-L of NF-L KO mice 
and WT controls at 12 months of age (n=3/group). Equal amounts of tissue were 
separated on a gel and labeled with the pTDP-43 antibody. Relative amounts of the 
protein expression of pTDP-43 were normalized against GAPDH (*p<0.05).  
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and 12-month old NF-L KO mice and age-matched WT mice, respectively. There 
was no signifcant (p<0.05) difference in pTDP-43 protein abundance in the CTX, 
HIP and CC of NF-L KO and WT mice at 10 weeks (Figure 4.13) and 12 months of 
age (Figure 4.14). However, in addition to two bands at 25 kDa and 45 kDa of 
pTDP-43 detected in CTX, HIP and CC of WT and NF-L KO mice at 10 weeks and 
12 months, the CC of the ageing brain of WT and NF-L KO mice, has an unusual 
band at approximately 37 kDa (Figure 4.14), which was not observed in the CTX and 
HIP. These findings suggest that in CC of aged brain, there are some subtle changes 
in the banding patterns of pTDP-43 or postranslational modification of pTDP-43 
species, without a change of the amount of pTDP-43 bewteen WT mice and NF-L 
mice. 
 
  
 
 
 
 
Figure 4.13 Western blot analysis of pTDP-43 protein expression in the CTX,  HIP 
and CC of NF-L KO mice and WT controls at 10 weeks of age (n=3/group). Equal 
amounts of tissue were separated on a gel and labeled with pTDP-43 antibody. 
Relative amounts of the protein expression of pTDP-43 were normalized against 
GAPDH.  

  
 
 
 
 
 
 
Figure 4.14 pTDP-43 protein expression in the CTX, HIP and CC of NF-L KO mice 
and WT controls at 12 months of age (n=3/group). Equal amounts of tissue were 
separated on a gel and labeled with pTDP-43 antibody. Relative amounts of the 
protein expression of pTDP-43 were normalized with GAPDH.  
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4.4  Discussion 
TDP-43 is involved in nuclear-cytoplasmic shuttling of RNA granules including NF-
L, NF-H and actin mRNAs to the neurites (Strong et al., 2007). In addition, TDP-43 
can function as a NF-L mRNA 3'UTR binding protein, influencing the stability of 
NF-L transcripts (Strong et al., 2007). Moreover, the interaction of TDP-43 with the 
NF-L mRNA 3' UTR involves UG motifs present on stem loops of the 3'UTR as well 
as the RRM1 and RRM2 motifs of TDP-43 (Strong et al., 2010). However, the 
interaction between NF-L and TDP-43 during ageing remains undefined. Based on 
the previous findings that deficiency of NF-L protein results in significant alterations 
of the expression of other NF proteins and neurofilamentous aggregates in the CTX 
at various ages (Chapter 3), this chapter examined the relationship between NF-L 
and TDP-43 in young and aged NF-L KO mice. This chapter is the first report to 
demonstrate that the lack of NF-L was associated with increased expression of TDP-
43 proteins in 10-week and 12-month old mice, strongly suggesting a close 
association between NF-L and TDP-43. In this regard, NF-L may be a negative 
regulator of TDP-43. This is consistent with a previous report showing increased 
TDP-43 proteins in injured young NF-L KO mice (Mossie et al., 2009), which 
indicated that, in the absence of NF-L mRNA, TDP-43 is free to interact with other 
mRNA substrates and TDP-43 can potentially act in a “dominant-negative” fashion 
to regulate NF-L mRNA stability (Mossie et al., 2009).   
 
Overexpression of the human TDP-43 gene induces motor neuron degeneration in 
transgenic mice (Wils et al., 2010). In addition, increased expression of the TDP-43 
gene has been reported to be neurotoxic to neurons and glia. Although the 
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mechanisms behind this are currently unclear toxicity may be due to both a 
hyperactive innate immune response resulting in toxicity on neuronal cells in 
addition to an increased vulnerability to a toxic environment (Kabashi et al., 2009; 
Wils et al., 2010). Neuronal sensitivity to TDP-43 overexpression is dependent on 
timing of induction (Cannon et al., 2012).  In this thesis, it was found that the lack of 
NF-L leads to TDP-43 overexpression without cytoplasmic aggregates, which is 
consistent with the previous studies that neuronal overexpression of WT or mutant 
TDP-43 in transgenic mice did not cause cytoplasmic TDP-43 aggregates 
(Wegorzewska et al., 2009; Stallings et al., 2010; Wils et al., 2010; Xu et al., 2010), 
although it did cause a dose-dependant degeneration of cortical and spinal motor 
neurons. This raises the possibility that an up-regulation of TDP-43, rather than 
TDP-43 cytoplasmic aggregates, may contribute to neurodegeneration by triggering 
pathogenic pathways, eg,  via NF-κB activation (Swarup et al., 2011b).   
 
In this chapter, aged NF-L KO animals exhibited worse motor dysfunction than 
younger KO animals, suggesting that ageing is a risk factor in the NF-L KO mice. 
Interestingly cortical and lumbar regions were pathologically vulnerable to NF-L 
mRNA reduction during ageing, resulting in an increase of TDP-43. Whether the 
vulnerabillity of these regions to increased TDP-43 is correlated to the alterations in 
motor function remains to be determined. 
 
Phosphorylation of TDP-43 is a consistent feature in all sporadic and familial forms 
of TDP-43 proteinopathies (Neumann et al., 2009). In this thesis, the band patten of 
the pTDP-43 immunoblot demonstrated two bands at 25 kDa and 45 kDa, with 
additional fragments. The labelling intensity of the 25 kDa band was higher than 
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45kDa band, which was similar to reports on TDP-43 in ALS/FTLD (Hasegawa et 
al., 2008). Phosphorylation of full-length TDP-43, resulting in a product of 45 kDa, 
was first observed in FTLD-U and ALS brains (Neumann et al., 2006). However, in 
this thesis, this 45 kDa band was not observed with the phosphorylation-independent 
TDP-43 antibody in the NF-L KO mice. In addition, cytoplasmic accumulation of 
phosphorylated TDP-43 was absent in neurons of NF-L KO mice. These data suggest 
that increases in TDP43 do not necessarily correlate with increased expression of 
pTDP-43 or abnormal cellular localisation. Interestingly, TDP-43 protein expression 
has been reported to be upregulated 1.5 times in ALS patients (Mishra et al. 2007; 
Gitcho et al. 2009). In the current study, the percentage of TDP-43 upregulation was 
approximately 20% in the CTX and 41% in the SC-L of NF-L KO mice, compared to 
WT controls. Upregulation of TDP-43 alone may not be sufficient to cause 
cytoplasmic accumulations and extensive phosphorylation. 
 
The band pattens of pTDP-43 immunoblots were different in the CC of both WT and 
NFL-KO mice at 12 months of age, as compared to the CTX and HIP of age-
matched WT and NF-L KO mice. The CC of the brain had an unusual band at 37 
kDa, which was not detected in the CTX and HIP. This finding is similar to a 
previous report that there was a band of pTDP-43 at about 30 kDa in FTLD-U type 3 
pathology case that is associated with cortical and spinal tract degeneration 
(Neumann et al., 2009).  
 
In conclusion, the findings in this chapter indicate that the absence of NF-L results in 
a small but significant increase in TDP-43, without cytoplasmic accumulations in 
CNS and motor dysfuntion in young and ageing animals, supporting the proposal 
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that upregulation of TDP-43 alone may not be sufficient to cause cytoplasmic 
accumulations and extensive phosphorylation. 
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Chapter 5: Myelination is altered in young and aged NF-L KO 
mice 
 
5.1  Introduction 
Oligodendrocytes are the glial cells that produce myelin sheaths around axons in the  
CNS (reviewed in Baumann and Pham-Dinh, 2001). Increasing evidence indicates 
that disturbance of myelination is associated with disease progression in many 
neurological conditions (Lazzarini 2004; Mitew et al., 2010; Philips et al., 2013). In 
addition, it has been proposed that non-neuronal cells, such as oligodendrocytes, may 
play an important role in neurodegeneration (Lee et al., 2012). Recently, 
oligodendrocytes have been particularly implicated in ALS pathogenesis with studies 
in human patients showing degeneration of oligodendrocytes, particularly in the grey 
matter of the spinal cord, which is compensated by increased proliferation and 
differentiation of oligodendrocyte precursor cells (Philips et al., 2013). However, 
these newly differentiated oligodendrocytes demonstrated reduced MBP suggesting 
that they are dysfunctional (Philips et al., 2013). Moreover, it has been reported that 
aberrant localization of TDP-43 to the cytoplasm rather than the nucleus, which is a 
morphological hallmark of the neuropathology of sporadic ALS, is not limited to 
motor neurons, but also occurs in oligodendrocytes (Neumann et al., 2007). 
 
Substanital evidence suggests a complex interplay of signalling between myelinating 
cells such as oligodendrocytes and the axon (reviewed in Nave et al., 2008; Brahic et 
al., 2009). Myelination (in the CNS and PNS) plays a critical role in expansion of 
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axonal diameter through its interation with structural proteins such as NFs (de 
Waegh et al., 1992), which is referred to as radial axonal growth (Ohara et al., 1993; 
Zhu et al., 1997). The modulation of axonal caliber by myelin appears to be linked to 
changes in the phosphorylation state and dynamic behavior of NFs (de Waegh et al., 
1992). The C-terminal 426 amino acid tail of the NF-M subunit is a determinant of 
axonal diameter in large caliber myelinated axons (Garcia et al., 2003; Rao et al., 
2003). In adddition, variations in the number of KSP repeats within the NF-M 
carboxy terminal tail may contribute to an increase in axonal caliber (Barry et al., 
2010). In this regard, MAG is known to signal to the axon, locally influencing the 
expression and phosphorylation of axonal NFs and their associated kinases (Hsieh et 
al., 1994; Dashiell et al., 2002; Nguyen et al., 2009). MBP protein is essential for the 
formation and maintenance of myelin in the CNS, and also interacts with 
cytoskeletal and signaling proteins such as MAG (Lazzarini, 2004; Vassall et al., 
2013).  
 
The effect of axonal signals on myelination, however, is less clear, although it is 
known that myelination is more likely to occur in larger caliber axons (Lazzarini, 
2004) and that a number of axonal signals are responsible for induction of 
myelination of small caliber axons (reviewed in Nave et al., 2008). Recent studies 
have identified biophysical and signalling based mechanisms that are involved in 
axonal selection and myelin sheath generation by oligodendrocytes (Simons et al., 
2013). Although demyelination is thought to be able to cause axonal degeneration (in 
diseases such as multiple sclerosis (MS) (Lazzarini, 2004), it is currently unclear 
how axonal abnormalities affect myelination (Simons et al., 2013). 
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A previous study has reported that the diameter of axons of upper motor neurons in 
the spinal cord of 2- and 6-month-old NF-L KO mice was decreased significantly 
while the thickness of their myelin sheath increased substantially (Zhu et al., 1997; 
Wu et al., 2008), indicating that NFs play a key role in maintaining axonal caliber. 
However, the effect of axonal NF alterations on myelination in the brain is not 
known. Furthermore, it is unclear how age-related changes in cytoskeletal proteins 
affect the structure and integrity of the myelin sheath. This thesis used a mouse 
model (NF-L KO mice), to determine the effects of the lack of NF-L on myelin 
proteins, and how this may be  affected by ageing.  
  
Chapter 3 showed that the absence of the NF-L gene and related protein resulted in 
the accumulation of other NFs in ageing neurons. In order to determine whether 
deficiency of the NF-L protein and reduced NFs result in myelin alterations during 
brain maturation and ageing of the CNS, this chapter investigated the relative protein 
levels and localisation of MBP and  PLP in three regions of brain including CTX, 
HIP and CC, and three regions of spinal cord including SC-C, SC-T and SC-L of 10-
week-old and 12-month-old NF-L KO mice relative to age-matched WT mice 
(C57BL/6). This chapter also measured the expression of CNPase in the brain of 
aged NF-L KO mice. This Chapter demonstrates that protein levels of MBP in the 
CTX and PLP in the CC are significantly reduced in the young and aged NF-L KO 
mice, supporting the proposal that NF-L is critical for the normal development and 
regulation of myelination. 
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5.2  Materials and Methods  
5.2.1 Tissue preparation 
For Western blot studies, protein samples of CTX, HIP, CC, SC-C, SC-T and SC-L  
from WT and NF-L KO mice at 10 weeks and 12 months of ages (n=3/group) were 
prepared as described in Section 2.3.1. For immunofluorescence studies, 40 µm 
coronal cryostat sections of  brain and spinal cord from WT and NF-L KO mice at 10 
weeks and 12 months of age (n=3/group) were prepared as described in Section 
2.2.1.   
 
5.2.2 Western blot  
Proteins from the tissue samples of 10-week and 12 month-old NF-L KO mice and 
WT controls (n=3 each) were extracted as described  in Section 2.3.2.  Proteins (15 
µg) were separated by 4-20% SDS-PAGE and blotted onto a PVDF membrane as 
described in Section 2.3.3. Primary antibody (Table 2.1) binding was visualised by 
goat anti-mouse or anti-rabbit IgG coupled to horseradish peroxidase (Dako, 
Denmark; Table 2.2). Immunoreactive bands were visualized and measured as 
described in Section 2.3.3.   
 
5.2.3 Immunofluorescence 
 
40 µm brain or spinal cord cryostat sections were washed with 0.01M PBS, followed 
by antigen retrieval and blocking of non-specific binding sites as described in 
Section 2.2.2. Sections were then incubated overnight at 4°C with primary antibodies 
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(Table 2.1) in diluent (0.3% Triton X-100, 0.01M PBS) as described in Section 2.2.3. 
Sections were washed with 0.01M PBS and incubated with Alexa Fluor 546 
conjugated to a goat anti-rabbit secondary antibody or Alexa Fluor 488 conjugated to 
goat anti-mouse IgG (Molecular Probes, United States; Table 2.2). Sections were 
washed with PBS before mounting onto Fisher Super Frost Plus slides using 
fluorescent mounting medium (Dako, Denmark), and air-dried in the dark.   
  
5.2.4 Data Collection and Analyses 
Fluorescence-labeled sections were viewed with a Zeiss LSM 510 META confocal 
microscope (Carl Zeiss, Germany) and images acquired as described in Section 2.4.   
 
For all experiments, a minimum of three mice was utilized for quantitative analysis 
as described in Section 2.6. Significance was determined by ANOVA and p<0.05 
was considered as significant. 
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5.3 Results 
5.3.1 MBP expression in the brains and spinal cords of young NF-L KO and WT 
mice  
MBP is involved in the development, compaction, and stabilization of the 
multilamellar myelin sheath, and also interacts with cytoskeletal proteins (Harauz et 
al., 2004; Lazzarini, 2004; Philips et al., 2013). To quantify changes in myelination 
in the early stage of NF-L KO mice development, this thesis first examined MBP 
protein levels of NF-L KO mice at 10 weeks of age, compared to age-matched WT 
mice, by Western blot analysis of brain and spinal cord lysates. To determine 
whether there were regional alterations in the levels of MBP, this thesis studied three 
regions of brain—CTX, HIP, CC and three regions of spinal cord—SC-C, SC-T and 
SC-L. Three major MBP bands (17, 21 and 33 kDa) were detected by Western blot 
in all samples. When the density of all three MBP bands was measured together for 
quantification, there was a significant decrease (p<0.05) of MBP protein in the CTX 
of 10-week old NF-L KO compared to WT controls (Figure 5.1), but no difference 
with respect to the HIP and CC samples. In addtion, MBP protein levels were 
significantly decreased (p<0.05) in SC-T samples, but not for the SC-C and SC-L, 
from NF-L KO mice as compared to WT mice at 10 weeks of age (Figure 5.2).  
 
5.3.2 MBP expression in the brains and spinal cords of 12-month old NF-L KO 
and WT mice  
To determine if the expression of MBP was affected by ageing in NF-L KO mice, 
this thesis studied the expression of MBP in the CTX, HIP, CC, SC-C, SC-T and SC-
  
 
 
 
 
 
Figure 5.1 Western blot analysis of MBP protein expression in the CTX, HIP and 
CC of NF-L KO mice and WT controls at 10 weeks of age (n=3/group). Equal 
amounts of tissue sample were separated on a gel and labeled for MBP. Relative 
amounts of the protein expression of MBP were normalized against GAPDH 
(*p<0.05).  

  
 
 
 
 
 
Figure 5.2 Western blot analysis of MBP protein expression in the SC-C, SC-T, SC-
L of NF-L KO mice and WT controls at 10 weeks of age (n=3/group). Equal 
amounts of tissue sample were separated on a gel and labeled with MBP. Relative 
amounts of the protein expression of MBP were normalized against GAPDH 
(*p<0.05).  
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L of NF-L KO animals relative to WT mice at 12 months of age by Western blot 
analysis. It was observed that, similar to young mice, the protein level of MBP was 
significantly reduced (p<0.05) in the CTX of 12-month-old NF-L KO mice, but not 
for the HIP and CC, compared with age-matched WT mice (Figure 5.3). In addtion, 
MBP protein levels were significantly decreased (p<0.05) in the SC-T of NF-L KO 
mice at 12 months of age, compared to WT controls, but there was no statistical 
difference with respect to the SC-C and SC-L samples. (Figure 5.4). 
 
To further study the expression of MBP in the CTX of ageing NF-L KO mice, 40 µm 
brain sections from 12-month old NF-L KO mice and from age matched controls 
were immunolabelled with antibodies against MBP. MBP labelling was decreased in 
the CTX of NF-L KO mice (Figure 5.5 B) at 12 months of age, compared to WT 
mice (Figure 5.5 A). 
 
5.3.3 PLP protein expression in the brains and spinal cords of WT and NF-L 
KO mice at 10 weeks of age 
In addition to MBP, PLP is another major protein of membranes of the myelin sheath 
in the CNS (Lazzarini, 2004; Philips et al., 2013). To further quantify changes in 
myelination in early stage of NF-L KO mice, protein samples from the CTX, HIP, 
CC, SC-C, SC-T and SC-L of NF-L KO mice and WT controls at 10 weeks, were 
immunoblotted with an antibody to PLP. A single PLP band (30 kDa) was detected 
by Western analysis. PLP was significantly decreased (p<0.05) in the CC of NF-L 
KO mice at 10 weeks, but not for the CTX and HIP, compared with age-matched 
WT mice (Figure 5.6). In the SC-L of 10-week-old NF-L KO mice, PLP abundance 
  
 
 
 
 
Figure 5.3  Western blot analysis of MBP protein expression in the CTX, HIP and 
CC of NF-L KO mice and WT controls at 12 months of age (n=3/group). Equal 
amounts of tissue sample were separated on a gel and labeled with MBP. Relative 
amounts of the protein expression of MBP were normalized against GAPDH 
(*p<0.05).  

  
 
 
 
 
 
 
Figure 5.4 Western blot analysis of MBP protein expression in the SC-C, SC-T, SC-
L of NF-L KO mice and WT controls at 12 months of age (n=3/group). Equal 
amounts of tissue were separated on a gel and labeled with MBP. Relative amounts 
of the protein expression of MBP were normalized against GAPDH (*p<0.05).   

  
 
 
 
 
 
 
Figure 5.5 Confocal images of MBP labeling in the CTX of WT (A) and NF-L KO 
(B) mice at 12 months of age. Scale bars, A, B 100 µm. 

  
 
 
 
 
Figure 5.6 Western blot analysis of PLP protein expression in the CTX, HIP and CC 
of NF-L KO mice and WT controls at 10 weeks of age (n=3/group). Equal amounts 
of tissue sample were separated on a gel and labeled with PLP. Relative amounts of 
the protein expression of PLP were normalized against GAPDH (*p<0.05). 

Chapter 5 – Results  
 
105 
" 
was significantly (p<0.05) lower than that in WT mice, but there was no difference 
with respect to the SC-C and SC-T samples. (Figure 5.7).  
 
5.3.4 PLP protein expression in the brains and spinal cords of 12-month-old NF-
L KO and WT mice  
To determine if the expression of PLP was affected by ageing in NF-L KO mice, 
Western blot analysis was used to investigate the protein levels of PLP in brain and 
spinal cord of 12-month-old WT and NF-L KO mice. The protein levels of PLP were 
significantly  (p<0.05) decreased in the CC of 12-month-old NF-L KO mice,  
compared with age-matched WT mice (Figure 5.8). However, there was no 
significant change of PLP protein levels in the SC-C, SC-T and SC-L of NF-L KO 
mice at 12 months of age, compared to WT controls (Figure 5.9). 
 
5.3.5 The protein expression of CNPase in the brains of 10-week-old and 12-
month-old NF-L KO mice 
The protein expression levels of CNPase, a structural component of myelin (Braun et 
al. 2004), were assessed by densitometric analysis of Western blots. The expression 
levels of CNPase were not significantly altered in the brain (CTX, HIP and CC) 
between WT and NF-L KO mice at 10 weeks (Figure 5.10) or 12 months (Figure 
5.11) of age.  
  
 
 
 
 
Figure 5.7  Western blot analysis of PLP protein expression in the SC-C, SC-T, SC-
L of NF-L KO mice and WT controls at 10 weeks of age (n=3/group). Equal 
amounts of tissue sample were separated on a gel and labeled with PLP. Relative 
amounts of the protein expression of PLP were normalized against GAPDH 
(*p<0.05).  

  
 
 
 
 
Figure 5.8  Western blot analysis of PLP protein expression in the CTX, HIP and 
CC of NF-L KO mice and WT controls at 12 months of age (n=3/group). Equal 
amounts of tissue sample were separated on a gel and labeled with PLP. Relative 
amounts of the protein expression of PLP were normalized against GAPDH 
(*p<0.05).  

  
 
 
 
Figure 5.9 Western blot analysis of PLP protein expression in the SC-C, SC-T, SC-L 
of NF-L KO mice and WT controls at 12 months of age (n=3/group). Equal amounts 
of tissue sample were separated on a gel and labeled with PLP. Relative amounts of 
the protein expression of PLP were normalized against GAPDH.  

  
 
 
 
 
 
Figure 5.10 Western blot analysis of CNPase protein expression in the CTX, HIP 
and CC of NF-L KO mice and WT controls at 10 weeks of age (n=3/group). Equal 
amounts of tissue sample were separated on a gel and labeled with CNPase. Relative 
amounts of the protein expression CNPase were normalized against GAPDH.  

  
 
 
 
Figure 5.11 Western blot analysis of CNPase protein expression in the CTX, HIP 
and CC of NF-L KO mice and WT controls at 12 months of age (n=3/group). Equal 
amounts of tissue sample were separated on a gel and labeled with CNPase. Relative 
amounts of the protein expression of CNPase were normalized against GAPDH. 
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5.4  Discussion 
MBP and PLP proteins are the major proteins of CNS myelin (Lazzarini, 2004). 
However, whether there is an interaction between NF-L and myelin in the CNS 
during ageing remains undefined. Based on the previous findings in Chapter 3 and 4, 
this chapter sought to determine the relationship between NF-L and myelin in the 
CNS by examing the expression of MBP, PLP and CNPase proteins in the CNS of 
10-week old and 12-month old NFL-KO mice. 
 
Previous reports have shown that the alteration in NF content in axons of NF-L KO 
mice results in both a decrease in axonal diameters and an increase in the thickness 
of myelin sheath (Zhu et al., 2007; Wu et al., 2008). These prior studies on myelin 
were only in the SC of NF-L KO mice up to the age of 6 months. The data presented 
in this chapter confirm and extend that of other studies on the myelination changes in 
NF-L KO mice. This chapter is the first report on the expression of MBP and PLP 
proteins in the CTX, HIP, CC, SC-C, SC-T, SC-L of young and aged NF-L KO mice 
as compared to age-matched WT controls. It was found that myelin proteins were 
reduced in some regions of CNS between NF-L KO and WT mice, such as MBP 
protein in CTX and SC-T, as well as PLP protein in CC and SC-L. However, most 
myelin proteins in most CNS regions investigated were not differentially expressed 
relative to WT samples. 
  
The data presented in this chapter suggest that the deletion of NF-L is associated 
with the decrease of myelin-associated proteins in particular regions of the brain, 
particularly MBP proteins in the CTX and PLP protein in the CC.  
Chapter 5 – Results  
 
107 
" 
 
In this chapter, although there were some differences in myelin protein levels in 
particular regions of CNS between NF-L KO and WT, most myelin proteins (such as 
CNPase) were not different between these groups. These results are consistent with 
the data reported previously that no obvious changes in expression of CNPase and 
MAG proteins, as OL markers, were detected in the brain and spinal cord of NF-L 
KO mice and WT controls at 2 and 6 months, and that the number of 
oligodendrocytes is maintained in young NF-L KO mice (Wu et al., 2008). 
 
NFs are major determinants of axonal caliber in large myelinated nerve fibers and 
NF phosphorylation is regulated by myelination of neurons (Garcia et al., 2003; Rao 
et al., 2003). A previous study has shown that the absence of NF-L results in an 
increase in the thickness of myelin sheaths and/or decrease in the diameter of axons 
in the spinal cord (Wu et al., 2008). MBP, the main myelin protein in CNS, plays 
roles both in myelin development and homeostasis by interacting with cytoskeletal 
proteins, such as actin and tubulin (Harauz et al., 2004; Vassall et al., 2013). The 
reduced MBP protein in the SC-T and PLP protein in the SC-L of NF-L KO mice, 
may arise from less axons becoming myelinated in KO animals caused by NFs 
disruption. Alternatively, the same proportion of axons may be myelinated but the 
thickness may be changed. Combined with the motor dysfuntion in NF-L KO mice 
shown in Chapter 4, the findings in this chapter suggest that the alteration of 
expression of MBP and PLP proteins in some region of spinal cord may influence 
normal axon physiology and motor functions of NF-L KO mice. 
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In conclusion, the findings in this chapter suggest that the loss of NF-L can cause the 
reduced expression of MBP and PLP proteins in some regions of CNS in young and 
aged mice, potentially contributing to the motor dysfuntion, without the change of 
other myelin proteins (such as CNPase protein) in the CNS, under the condition of 
CNS compensating for the loss of NF-L described in Chapter 3 and 4.  
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Chapter 6: General Discussion and future studies  
 
NF proteins play a key role in the maintenance and remodeling of the neuronal 
cytoskeleton, and seem to contribute to several neurodegenerative diseases. 
However, the detailed functions of NF proteins in the neuronal cytoskeleton, also 
with respect to myelination and neurodegenerative disease-related proteins, remains 
unknown. This thesis primarily sought to investigate the consequences of the lack of 
NF-L on the adaptive capacity of the neuronal cytoskeleton in adulthood and ageing, 
as well as the consequences related to myelination and the NF RNA-binding protein 
(TDP-43), in order to understand the functions of NFs in neuronal cell biology, 
ageing and neurodegenerative diseases.   
 
6.1 Summary of the main findings 
In summary, the data presented in this thesis suggest that the loss of NF-L causes a 
functional impairment, as well as interesting changes in neurodegenerative disease-
related proteins such as TDP-43, but, overall, there seems to be a range of 
compensatory mechanisms in the CNS in response to the absence of NF-L. 
Additionally, the changes in cytoskeletal proteins, TDP-43 protein, myelin proteins 
and motor function caused by the loss of NF-L have some differences between 
young and aged NF-L KO mice.    
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6.1.1  Adaptive capacity of the cytoskeleton 
It was reported in this thesis (Chapter 3) that lack of NF-L protein was associated 
with significantly decreased expression of dephosphorylated NFs, NF-M and INT 
proteins in adult (5 months) NF-L KO mice, while significantly reduced protein 
levels of phosphorylated NFs and increased INT protein level in aged (12 months) 
NF-L KO mice. For the protein levels of  NF-P, there was a greater decrease in aged 
NF-L KO mice than in adult NF-L KO mice, compared to age-matched-WT controls. 
In addition, protein levels of class III neuron-specific beta-tubulin and MAP2 were 
significantly increased in both adult and aged NF-L KO mice. These findings from 
this thesis indicate that the absence of NF-L leads to disruption of other NF subunits, 
causing intracellular aggregation without gross structural changes in cortical neurons.   
 
6.1.2 Reactive changes in disease-related proteins such as TDP-43 in young and 
aged NF-L KO mice 
As described in Chapter 4, the expression of TDP-43 proteins was relatively 
increased in the CTX of aged (12 months) NF-L KO mice. However, there were no 
signifcant changes in the levels of TDP-43 protein in the CTX, HIP or CC between 
young (10 weeks) NF-L KO and WT mice. In addition, the changes in the spinal 
cord also differed from young and aged NF-L KO mice. In young mice, the 
expression levles of TDP-43 were significantly increased in all three regions of 
spinal cord, including SC-C, SC-T and SC-L; while in aged NF-L KO mice, the 
protein level of TDP-43 was only significantly increased in the SC-L. In both the 
CTX and SC-L of aged NF-L KO mice, there were no pathologic accumulations of 
TDP-43. For the protein levels of pTDP-43, there were no significant changes in the 
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CTX, HIP and CC of both young and aged NF-L KO mice relative to WT controls. 
Moreover, the changes in the level of pTDP-43 protein in the spinal cord differed 
between young and aged NF-L KO mice. The expression of pTDP43 was 
significantly increased in the SC-T of young NF-L KO mice and in the SC-C of aged 
NF-L KO mice, compared to WT controls. However, there were no significant 
alterations in the expression of pTDP-43 protein in the CTX, HIP and the CC of 
young and aged NF-L KO mice.  
 
6.1.3 Alterations in myelin proteins 
The data in Chapter 5 indicated that the deletion of NF-L resulted in the decrease of 
MBP proteins in the CTX, SC-T and PLP proteins in the CC in both young (10 
weeks) and aged (12 months) NF-L KO mice, relative to WT mice. In addition, there 
was a significant decrease in the expression of PLP protien in the SC-L of young NF-
L KO mice. However, there were no significant alterations of the expression of PLP 
proteins in the SC-C, SC-T and SC-L of ageing NF-L KO mice and no significant 
changes of CNPase proteins in the CTX, HIP and CC of young and aged NF-L KO 
mice, compared to age-matched WT controls. 
 
6.1.4 Functional deficits 
This thesis (Chapter 4) demonstrated that both young (4 months) and aged (12 
months) NF-L KO mice showed motor dysfunction. Additionally, the motor 
dysfunction of aged NF-L mice was worse than that of young NF-L mice. 
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6.2 Discussion and implications of main thesis findings 
The individual chapters in this thesis have discussed extensively the findings from 
each of the three main studies undertaken. The remainder of this discussion will 
therefore examine the broader findings of this thesis. 
 
6.2.1 The cellular changes induced by loss of NF-L  
 
The findings in this thesis illustrate that the loss of NF-L can produce cytoskeletal 
changes and alteration of TDP-43 and myelin proteins at the cellular level.  
 
Cytoskeletal abnormalities have been described during neurodegenerative processes, 
such as in ALS (reviewed in Liu et al., 2004a). In addition, alterations in the 
stoichiometry of NF expression has been demonstrated in ALS (Wong et al., 2000). 
The data presented in this thesis suggest that the loss of NF-L affects the remainder 
of the cytoskeleton by causing disruption of other NF proteins as well as 
compensatory increase of some element proteins of MTs.  
 
Oligodendrocytes can establish myelin and provide metabolic support to neurons 
(Lee et al., 2012). ALS-linked genes have been proposed to accelerate disease by 
directly impairing the function of oligodendrocytes (Kang et al., 2013). The data 
from this thesis suggest that the absence of NF-L also results in alteration of 
expression levels of myelin proteins in oligodendrocytes and supports the hypothesis 
that the loss of NF-L may cause the impaired functions of oligodendrocytes in CNS 
(Zhu et al., 1997; Wu et al., 2008).  
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6.2.2  NFs contribute to the selective vulnerability of neurons and glia to 
pathology 
As discussed in Chapter 4, deletion of NF-L was associated with increased 
expression of TDP-43 proteins in the CTX and SC-L of aged animals. In addition, 
the data in Chapter 5 showed that the loss of NF-L resulted in the decrease in MBP 
protein levels in the CTX and PLP protein expression in the CC at 10 weeks and 12 
months of age. It is interesting that the absence of NF-L had specific regional effects 
in the CNS. The data from this thesis indicated that selective vulnerability could 
manifest at the cellular level, with specific regions of neuronal and glial populations 
being differentially affected by the absence of NF-L. These findings are similar to a 
previous report that the accumulation of pathologic TDP-43 protein is only found in 
layer 5 pyramidal neurons in frontal CTX and spinal motor neurons of TDP-43 
mutant transgenic mice, recapitulating the phenomenon of selective vulnerability 
(Wegorzewska et al., 2009). Furthermore, these findings are consistent with previous 
studies that NF alterations in different NF transgenic mice caused dysfunction of 
specific neuronal populations such as motor neurons (Cote et al., 1993; Xu et al., 
1993b; Lee et al., 1994; Collard et al., 1995) and Purkinje cells of the cerebellum (Tu 
et al., 1997).  
  
6.2.3  NF-L KO mice are phenotypically different from WT mice through 
adulthood and ageing 
Although the general behavior of NF-L KO mice was indistinguishable from that of 
WT controls, it has been reported that, as early as 6 months, depletion of the NF-L 
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protein is sufficient to cause mild sensorimotor dysfunctions and spatial deficits, but 
without overt signs of paresis, using T-maze, stationary beam, coat hanger, rotorod 
and water maze tests (Dubois et al., 2005). Deficits in these tests also have been 
found in NF-H LacZ transgenic mice (Lalonde et al., 1999), potentially attributable 
to reduced motor neuron axonal caliber (Eyer and Peterson, 1994) or Purkinje cell 
number (Tu et al., 1997). 
 
As discussed in Chapter 4, the data in this thesis showed that lack of NF-L resulted 
in motor dysfunction in both young and aged NF-L KO mice, indicating the 
relationship between motor function and the effects of NF-L deletion. These results 
suggest that the loss of NF-L is linked with gait abnormalities of animals, albeit NF-
L KO mice have no overt signs of paresis (Dubois et al., 2005). The likely cause of 
the motor dysfunction in NF-L KO mice may be due to retarded conduction velocity 
of peripheral nerves, as a result of reduced axonal caliber associated with lower 
density of NFs in these axons (Zhu et al., 1997; Kriz et al., 2000). Moreover, the 
deficits may also be due to brain alterations (Dubois et al., 2005, and this thesis). It is 
not yet known why the NF-L KO animals show a motor deficit from early ages (4 
months), and this motor deficit was amplified in the same mouse model during 
ageing (12 months). The most likely explanation is that the loss of NF-L causes the 
dysfunction of NFs and the impairment in NFs in NF-L mice increases with age.  
 
6.2.4 The nervous system compensates for the absence of NF-L  
Consistent with the previous reports (Conde et al., 1994; DeFelipe et al., 1999; Park 
et al., 2000; Yamashita et al., 2003), the data presented in this thesis implied that lack 
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of NF had no effect on overall cortical structure and there were no changes in the 
expression of particular myelin proteins, as well as TDP43 and pTDP43 protein in 
some regions of CNS, which indicated the ability of the nervous system to 
compensate for the loss of NF-L and reduced neurofilaments.  
 
Increased protein expression of other cytoskeletal components (class III neuron-
specific beta-tubulin and MAP2) in both adult and aged NF-L KO mice may be 
reflective of compensatory changes taking place in the CNS. Combined with a 
previous study (Zhu et al., 1997), this finding may explain why NF-L KO mice 
exhibit general behaviors indistinguishable from WT mice, without a major 
neurological/behavioural phenotype (Dubois et al., 2005). The adaptive changes in 
other cytoskeletal proteins underlines the inter-relationship of NFs, MTs and MFs in 
maintaining neuronal structure and function (reviewed in Julien et al., 2000). 
Associated with a recent study (Blizzard et al., 2013), the data from this thesis 
suggests that the loss of NF-L can partially be compensated for by increased INT 
expression, reflecting a partially adaptive response in which INT may act as a 
substitute for NF-L in the assembly of NFs, albeit the density of these structures is 
reduced in axons (Blizzard et al., 2011, 2013). Additionally, the small increases of 
TDP-43 without aggregates in some regions of the CNS in NF-L KO mice may be 
due to the ability of the CNS to compensate for the absence of NF-L. These findings 
support the hypothesis that the CNS may compensate for the lack of NFs by 
regulating these other elements through feedback loops which may be related to the 
retrograde transport of cytoskeletal proteins and resultant signalling (Zhu et al., 
1997; Li et al., 2006; reviewed in Yuan et al., 2012).    
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6.2.5 The role of NF-L in the nervous system  
Consistent with previous studies (Zhu et al., 1997; Wong et al., 2000; Li et al., 2006; 
Wu et al., 2008), the data presented in this thesis shows that lack of NF-L could lead 
to NF disruption including accumulation of other NF proteins during adulthood and 
ageing. This is consistent with a previous report that showed that alterations in NF-L 
mRNA stability were associated with intraneuronal NF aggregate formation (Ge et 
al., 2003). These findings indicate that, although INT may potentially compensate for 
the assembly of NFs, the loss of NF-L still results in NF abnormalities, supporting 
the previous studies on the important role that the NF-L subunit has in the assembly 
of NFTPs (Carter et al., 1997; Zhu et al., 1997; reviewed in Julien, 1999 and Liu et 
al., 2004a; reviewed in Yuan et al., 2012). These findings also support the proposal 
that NF-L plays an important role in the transport of NF proteins into axons by 
regulating the interaction between other NFs (Zhu et al.,1997; Perez-Olle et al., 
2005; reviewed in Yuan et al., 2012).  
 
Oligodendrocyte dysfunction leads to axon degeneration in several diseases (Lee et 
al., 2012). Increasing evidence indicates that NFs have an important role in 
oligodendrocyte development and myelin formation (Zhu et al.,1997; Wu et al., 2008; 
reviewed in Yuan et al., 2012; Blizzard et al., 2013). It has been reported that the 
regeneration of myelinated axons following crush injury of peripheral nerves was 
found to be abnormal in NF-L KO mice, which indicated that NF-L plays a critical 
role in the maturation of regenerating myelinated axons (Zhu et al., 1997; Blizzard et 
al., 2013). NF-L has been confirmed as a major determinant of axonal calibers in the 
ventral root of lower motorneurons of the spinal cord (Zhu et al., 1997). The 
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alteration in NF content in axons of NF-L KO mice resulted in both a significant 
decrease in axonal diameter and a significant increase in the thickness of the myelin 
sheath up to 6 months of age (Wu et al., 2008). The data on myelin proteins 
presented in this thesis confirms and extends other studies on the myelination 
changes in NF-L KO mice (Zhu et al., 1997; Wu et al., 2008), supporting the 
previous proposal that NF-L, a component of myelinated axons, and/or NF assembly, 
may play a direct role in maintaining the normal morphology of myelinated axons 
(Zhu et al., 1997; Okonkwo et al., 1998; Zhu et al., 2007; Wu et al., 2008).  
 
6.2.6 Could loss of NF-L be a primary driver of pathology in neurodegenerative 
disease and/or contribute to disease pathology? 
NF abnormalities related to neuronal dysfunction have been reported in many 
neurodegenerative disorders (Liu et al., 2004a). Additionally, TDP-43 pathology has 
been detected in ALS, PD, AD and FTLD (Amador-Ortiz et al., 2007a, b; Higashi et 
al., 2007; Bigio et al., 2008; Uryu et al., 2008). However, the relationship between 
TDP-43 pathology and NF abnormalities, and whether the loss of NF-L could be a 
primary driver of such pathology, remains unknown.  
 
It has been reported that miRNAs could be responsible for the selective suppression 
of NF-L mRNA in ALS (Campos-Melo et al., 2013). Several of the proteins 
associated with ALS have the capacity to regulate the stability of NF-L mRNA 
(Volkening et al., 2009), including TDP-43 protein, which stabilizes NF-L mRNA 
(Strong et al., 2007). The data from this thesis indicates that the deletion of NF-L is 
associated with NF aggregate formation and an increase of the expression of NF 
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RNA-binding protein (TDP-43). These findings provide evidence of a potential link 
between NF-L protein loss and TDP-43 protein, suggesting that NF-L protein is 
potentially a negative regulator of TDP-43 in the CNS (Moisse et al., 2009) and 
TDP-43 may play a role in maintaining the stability of NFs (Strong et al., 2007; 
Volkening et al., 2009). It is not yet known how NF-L regulates TDP-43. The most 
likely explanation is that NF-L is involved in the regulation of TDP-43 through a 
cell-signaling pathway. Early loss of NFs in the pathological cascade leading to 
neuronal degeneration has been described in PD (Gai et al., 2004) as well as AD 
(Vickers et al., 1992). Combined with these previous reports, the findings in this 
thesis support the proposal that NF-L has a putative role in mediating the response of 
the neuronal cytoskeleton through the signaling pathway linked to TDP-43 and the 
regulation of TDP-43 (Moisse et al., 2009; Ihara al., 2013). 
 
One of the common features of TDP-43 pathology is increased phosphorylation of 
this protein (Neumann et al., 2009). Several studies have shown that antibodies 
specific for pTDP-43 can recognize TDP-43 proteinopathies in humans (Hasegawa et 
al., 2008, Neumann et al., 2009) and in transgenic mice overexpressing TDP-43 
(Wils et al., 2010; Igaz et al., 2011; Cannon et al., 2012). The data presented in this 
thesis on the band pattern of pTDP43 immunoblots are similar to previous reports on 
ALS/FTLD (Hasegawa et al., 2008) and FTLD-U type 3 pathology cases (Neumann 
et al., 2009). 
 
As discussed in Chapter 4, although small upregulation of TDP-43 alone may not be 
sufficient to result in pathological accumulation of TDP-43 and extensive 
phosphorylation, it may be potentially linked with motor function impairments 
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associated with the loss of NF-L. This may be attributed to higher amounts of TDP-
43 producing more neurotoxic mediators to the neurons (Swarup et al., 2011a) and 
the loss of NF-L in the neurons increases their vulnerability to toxic mediators.  
 
The data presented in this thesis showed that the loss of NF-L may cause abnormally 
increased TDP-43, which was similar to a previous report that tau pathology 
generally preceded TDP-43 pathology. This indicated that TDP-43 pathology may 
arise as a secondary consequence of a primary proteinopathy (Clippinger et al., 2013) 
and/or cytoskeletal disruption. However, a previous report has shown that that NF-H 
protein was downregulated by 1.5-fold and NF-L protein by 2-fold in the spinal cord 
extracts of 10-month-old TDP-43 G348C mutant mice as compared with non-
transgenic mice, because of increased expression of TDP-43 (Swarup et al., 2011a). 
Combined with previous studies, the findings from this thesis suggest that loss of 
NF-L could contribute to disease-like pathological alterations including motor 
dysfunction and abnormal increase of TDP-43 without aggregates, although it 
doesn’t rule out the possibility that, in humans, the alterations of NFs are sufficient to 
drive TDP-43 pathology.  
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6.3 Future studies  
In this thesis, the effects of loss of NF-L on cytoskeletal proteins, NF RNA-binding 
protein and myelin proteins in vivo have been investigated by using young and aged 
NF-L KO mice. These findings have provided more insight into how the absence of 
NF-L affects the cytoskeleton, TDP-43 and myelination. However, the cellular 
model of NF-L deficiency is perhaps more useful to investigate the celluar signaling 
linked to TDP-43. Therefore, important future work would be to study the signaling 
pathway in vitro by using cultured neurons and glia from NF-L KO mice. 
 
In this thesis, the expression of myelin proteins including MBP, PLP and CNPase 
proteins in young and aged NF-L KO mice have been examined by Western blotting 
and immunochemistry. However, these biochemical studies are not sufficient for 
examining myelin structure and morphology. Therefore, studies of the thickness of 
myelin sheaths and diameter of myelinated axons in adult and aged NF-L KO mice 
are needed in future, as the information will help to more definitively delineate 
potential alteration of myelin sheaths in adult and aged NF-L KO mice. Thus, 
transmission electron microscope studies of myelin sheaths should be included in 
future studies.  
 
In this thesis, the motor dysfunction associated with the loss of NF-L protein were 
demonstrated in 4-month-old and 12-month-old NF-L KO mice. Thus, further study 
may require examination of motor impairments in younger mice (eg 1, 2 or 3 months 
old) to confirm whether the motor dysfunction begins from earlier stages of 
development. In addition, future work could involve an evaluation of the progression 
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of the motor dysfunction of NF-L KO mice together with cognitive evaluation to 
investigate the effects of loss of NF-L on both spinal cord and brain functions. 
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6.4 Conclusions 
• The absence of NF-L protein resulted in the alteration of NFs and other 
cytoskeletal proteins during adulthood and ageing. 
 
• Cortical and lumbar spinal cord regions were susceptible to TDP-43 
alterations in NF-L KO mice during ageing. 
 
• NF-L protein or mRNA is potentially a negative regulator for the expression of 
TDP-43 in the CNS. 
 
• The lack of NF-L protein resulted in the alteration of myelin proteins in both 
young and older animals. 
 
• The deletion of NF-L protein was associated with motor dysfunction of young 
and aged mice. 
 
This thesis has documented that the lack of NF-L alters the expression of 
cytoskeletal proteins and disrupts other NF subunits without gross structural changes 
in cortical neurons. In addition, the changes of NF results in the increase of TDP-43 
expression level, linked with motor function impairments, without pathologic 
accumulation. These findings provide new insights into the roles of NF in ageing and 
neuro-degenerative processes. 
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Appendix 
1. General Solutions 
0.01M phosphate buffered saline (PBS, pH 7.4), 1000ml 
100ml NaCl (Sigma)- 90g/L stock solution 
40ml  Na2HPO412H2O (Sigma) - 28.4g/L stock solution  
10ml NaH2PO4.H2O (Sigma)- 31.2g/L stock solution 
850ml Milli-Q water  
pH 7.4 
 
2. Immunohistochemistry solutions 
4% paraformaldehyde (PFA), 100ml  
4g PFA (Sigma) 
4g sucrose (Sigma) 
10ml  NaH2PO4.H2O (Sigma)- 31.2g/L stock solution 
40ml  NaH2PO4 (Sigma)- 28.4g/L stock solution 
50ml Milli-Q  water 
dissolved by heating (~80°C ) on stirrer hotplate in fume hood  
 
Diluent solution (0.3% Triton X-100 in 0.01M PBS) 
600µL    Triton X-100 (Sigma) 
200mL    0.01M PBS 
 
18% / 30% Sucrose, 1000ml 
 
180/300g sucrose (Sigma) 
1000 ml  0.01M PBS 
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Tissue Storage Solution, 1000ml 
1g             azide (Sigma) 
1000ml  PBS 
 
0.01M Citrate buffer, 1000ml 
 2.94g        Trisodium citrate in 800ml Milli-Q  water 
Dessolve and adjust to pH 6 with 0.1M citic acid, then Add Milli-Q water to 
reach   the final volume 1000ml 
 
3. Western blot solutions 
10 x transfer buffer, 1000ml  
144g       Glycine  (Sigma)  
30.3g      Tris base  (Sigma)      
Add Milli-Q water to reach the final volume 1000ml 
 
10 x TBS, 1000ml            
87.66 g    NaCl (Sigma)       
12.11g     Tris base  (Sigma)   
Add Milli-Q water to reach the final volume 1000ml 
 
10 x running buffer, 1000ml   
144g       Glycine  (Sigma) 
30.3g      Tris  base  (Sigma)  
10g         SDS  (Sigma)    
Add MilliQ water to reach the final volume 1000ml 
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1 x running buffer, 1000ml    
100 ml   10 x running buffer       
900 ml    MilliQ  water           
 
1 x transfer buffer, 1000ml      
100 ml   10x transfer buffer        
100 ml   Methanol            
800 ml    MilliQ  water    
                 
1 x TBST buffer, 1000ml     
 
    100 ml   10 x TBS  
900 ml   MilliQ water  
    1 ml   Tween  20 (Bio-Rad Laboratories) 
   
Blocking buffer, 50ml        
2.5g    Skim dry milk (Coles)               
50 mL  1x TBST    
 
 
 
 
 
